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Abstract
Multi-drug resistant tuberculosis (MDR-TB) patients in resource-poor settings experience large
delays in starting appropriate drug regimens and are often not monitored appropriately due to an
overburdened health care system, communication delays, and missing or error-prone data.
Medical information systems can be used to alleviate these problems by increasing the timeliness
and quality of laboratory information available.
The research reported in this thesis developed, implemented, and evaluated two such systems in
the urban, resource-poor setting of Lima, Peru in institutions with and without internet.
The first part addresses the electronic collection of tuberculosis (TB) laboratory information
from multiple institutions without internet. A handheld computer-based system was developed
and implemented. A cluster randomized controlled trial and before-and-after comparison
showed that this system had a significant effect in reducing processing times from 23 to 8 days,
the proportion of cultures with delays >90 days from 9.2% to 0.1%, the number of errors by
57.1%, and the work-hours necessary to process results by 60%. A cost and timeline framework
was developed to allow other organizations in resource-poor settings to implement this
technology.
The second part addresses a web-based system, e-Chasqui, developed to provide electronic
communication and reporting of TB laboratory information to health care personnel within
institutions with internet. A cluster randomized controlled trial showed that access to e-Chasqui
resulted in significantly less time to receipt of test results, a 56% reduction in tests taking over 60
days to arrive and a 98% reduction of results that never arrived, as well as a significantly faster
time to culture conversion among patients in intervention versus control centers.
These two parts describe verified medical informatics tools and an implementation methodology
for settings both with and without internet connectivity.
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1 Introduction
1.1 Motivation
Tuberculosis (TB) is a chronic infectious disease that kills over 2 million people per year in the
developing world. According to the World Health Organization (WHO), tuberculosis is second
only to AIDS as the most deadly infectious disease in the world. Multidrug-resistant
tuberculosis (MDR-TB) is now recognized as one of the most significant emerging infectious
diseases. MDR-TB has been documented in more than 100 countries throughout the world.1
Transmission "hot spots" exist on several continents, and the problem of MDR-TB continues to
grow.2 In developed countries, programs to treat MDR have demonstrated cure rates of up to
90%.3 Only recently have programs implemented in middle-income and poor countries also
shown promising results. 8
Multidrug-resistant tuberculosis in Lima, Peru
Incidence of TB in Peru is 162 per 100,000, second highest behind Bolivia.9 In the densely
populated periphery of metropolitan Lima, where half of all national cases are detected, the risk
of infection with M. tuberculosis is estimated to be among the highest levels documented
recently in any population.10-12 Tuberculosis remains the leading cause of death among
individuals between 15-59 years of age. 13
Rates of MDR-TB are also significant, with a national prevalence of 5.3% among patients never
before treated for TB (primary MDR-TB) and 23% among previously treated patients. 14 While
directly observed standardized short-course chemotherapy (DOTS) has been successfully
implemented in Peru since a reform in the early 1990's, the prevalence of MDR-TB continues to
rise; thus, on-going transmission of these strains makes DOTS alone an insufficient strategy to
control this epidemic.
The treatment of MDR-TB requires the use of second line anti-tuberculosis drugs, which are
more costly, more toxic, and less effective than first-line drugs. For these reasons, the clinical
management of these patients is complex and individual. The identification of patients with risk
factors for drug resistance; timely diagnosis through drug susceptibility testing; individual
regimens based on test results; and close clinical monitoring all require specialized laboratory
and clinical resources that are not easily implemented in resource-poor settings.
The motivation of this thesis is to improve patient care and reduce the transmission of drug
sensitive and resistant TB in resource poor settings with a high burden of disease by providing a
methodology for creating and implementing laboratory information systems, and performing
randomized controlled trials to measure their impact under program conditions.
1.2 Problem Identification
As TB programs continue to address the growing burden of drug-sensitive and drug-resistant TB,
there is increasing need for greater laboratory capacity and better information systems to manage
patient data that can be employed in resource-poor settings. Drug sensitivity tests (DST)
measure the medications to which the patient's TB is resistant. This test is fundamental in
determining the appropriate drug regimen to be given to the patient. Bacteriology tests, smear
and culture, comprise some of the most important clinical measures of treatment response. Each
MDR-TB patient on treatment should leave a monthly sputum sample at his or her local health
center for smear and culture tests.
Timeliness and accuracy of this data are essential to starting a patient on an appropriate drug
regimen and monitoring them throughout their 2 year treatment period. An observational study
in Peru has shown that despite the large increase in treatment capacity and decentralization of
laboratory capacity, patients still experience risky delays of several months in starting the correct
treatment and getting monitored appropriately. 5 For example, a Peruvian high school student
with MDR-TB was not appropriately treated because doctors assumed she had drug-sensitive
TB, a sample sent for DST was lost, and when she was started on an appropriate treatment, drug
supply issues kept her from receiving the medications. Due to this delay of over 2 years, she
now has permanent bilateral lung damage. 16 Our organization has seen many patients in this
situation where the lack of information management has led to worse patient outcomes. Prompt
treatment with individualized drug regimens based on DST improves patient outcomes' 7 and
reduces the risk of amplification of drug resistance and ongoing transmission'8 9
Information systems could be used to alleviate both of these major problems. Appropriately
designed web-based and off-line systems could virtually eliminate the time to communicate
results between different institutions and thus eliminate a major source of treatment start delays.
Further, analysis and data quality tools within the system could radically improve quality control,
eliminating lost results and delays in starting treatment. Decreasing the time to treatment and
ensuring an appropriate drug regimen should lead to improved patient outcomes and reduce the
transmission of this deadly disease. 20 As Raviglione and Smith comment in a recent editorial,
"information is essential to build a response [to drug-resistant diseases], and only computerized
information systems allow sufficiently rapid exchange of information within and between
21 ncountries .'
A key area for research in medical information systems is evaluating the usability and impact of
such systems. This is particularly important in assessing the impact on quality of care and
patient outcomes. This thesis proposes to perform such an evaluation of systems that have the
capacity to improve the quality of care provided to patients by increasing the timeliness and
quality of information available. Few studies have been able to convincingly demonstrate such
benefits in the US, and virtually none in resource-poor settings. 2224
1.3 Executive Summary
This thesis describes the design, development and deployment of two systems for TB
laboratories. It then reports results of a formal evaluation of their effects in the target
environment of MDR-TB care in Lima, Peru. Here I summarize the findings of the research
chapters of the thesis.
Part 1: Improve the method of collecting laboratory data from a distributed group of non-
networked TB laboratories by the use of a PDA-based system
1.3.1 Chapter 3 - Development and implementation of PDA-based system
This chapter describes the process of development and implementation of a PDA-based
electronic data system to collect TB bacteriological results for current MDR-TB patients from a
group of laboratories and health centers without internet in a low resource urban setting for
clinical and research purposes. This electronic system uses PDAs as the initial point of data
entry at the clinical site. The PDAs interface with the existing web-based medical record system
(PIH-EMR) over the internet. A new section within the PIH-EMR, created for this project,
contains pages to automate the validation of the data, generate the required forms, and transfer
data into the clinical section of the medical record system. This work was published in the
Proceedings of the 2006 AMIA Annual Conference.25
1.3.2 Chapter 4 - Evaluation of PDA-based system
We performed a cluster randomized controlled trial in 93 health establishments to evaluate the
effectiveness of the PDA-based system and compare this new system to the previous paper-based
system. The PDA- and paper-based systems were evaluated based on processing times,
frequency of errors, and number of work-hours expended by data collectors. Baseline data were
collected for 19 months. Districts (n=4) were then randomly assigned to intervention (PDA) or
control (paper) groups, and further data were collected for 6 months. Comparisons were made
between intervention and control districts and within-districts before and after the introduction of
the intervention.
The PDA-based system had a significant effect on processing times (p<0.001) and errors
(p=0.005). The median processing time for cultures and smears was reduced from 23 to 8 days
and 25 to 12 days, respectively, in the between-districts comparison. In that comparison, the
proportion of cultures with delays >90 days was reduced from 9.2% to 0.1% and the number of
errors was decreased by 57.1%. The intervention reduced the work-hours necessary to process
results by 70% and was preferred by all users. This work was published in the International
Journal of Infectious Diseases in 2008.26
1.3.3 Chapter 5 -Cost analysis of PDA-based system
The goal of this study was to assess the collection efficiency of each system and the resources
required to develop, implement, and transfer the PDA-based system to a resource-poor setting. I
performed a time-motion study of data collectors using the PDA-based or paper systems and a
cost analysis of developing, implementing, and transferring the PDA-based system to a local
organization and their further expansion of the system.
The study showed that work hours spent collecting and processing results decreased by 60%
(p<0.001) when using the PDA-based system. Users perceived this decrease to be 70% and had
no technical problems they could not fix. The total cost and time to develop and implement the
intervention was US$26,092 and 22 weeks. The cost to expand to 9 other districts was $1,125
and to implement collecting patient weights was $4,107. This work was published in the
International Journal of Tuberculosis and Lung Disease.27
Part 2: Improve clinical care by electronic communication and reporting of TB laboratory
results in a resource-poor setting with internet
1.3.4 Chapter 6 - Development and implementation of e-Chasqui, laboratory information
system
This chapter describes the web-based laboratory information system "e-Chasqui" that was
designed and implemented in Peru to improve the timeliness and quality of laboratory data. It
was deployed in the national TB laboratory, two regional laboratories and twelve pilot health
centers. Using needs assessment and workflow analysis tools, e-Chasqui was designed to provide
for improved patient care, increased quality control, and more efficient laboratory monitoring
and reporting.
Since its full implementation in March 2006, 29,944 smear microscopy, 31,797 culture and 7,675
drug susceptibility test results have been entered. Over 99% of these results have been viewed
online by the health centers. High user satisfaction and heavy use have led to the expansion of e-
Chasqui to additional institutions. In total, e-Chasqui will serve a network of institutions
providing medical care for over 3.1 million people. The cost to maintain this system is
approximately US$0.53 per sample or 1% of the National Peruvian TB Program's 2006 budget.
This chapter shows that electronic laboratory information systems have a large potential to
improve patient care and public health monitoring in resource-poor settings. Some of the
challenges faced in these settings, such as lack of trained personnel, limited transportation, and
large coverage areas, are obstacles that a well-designed system can overcome. This work was
published in BMC Medical Informatics and Decision Making. 127
1.3.5 Chapter 7 - Evaluation of e-Chasqui in reducing delays
This chapter describes the cluster randomized controlled trial performed to evaluate the
effectiveness of e-Chasqui compared to the current paper-based system. The e-Chasqui and
paper-based systems were evaluated based on the times to communicate a result, to start or
change a patient's treatment, and for that patient to culture convert. The trial was conducted in 78
health establishments in Lima, Peru. Baseline data were collected for 15 months. Health centers
were then randomly assigned to intervention (e-Chasqui) or control (paper) groups, and further
data were collected for at least 2 years. Comparisons were made between intervention and
control groups, as well as before and after the introduction of the intervention.
This study showed that intervention health centers took significantly less time to receive both
DST and culture results. They also had a significantly lower proportion of DSTs that had taken
over 60 days to arrive. The time to start or change a treatment was not significantly different
between control and intervention health centers, but those patients in intervention health centers
did have significantly lower time to culture conversion.
1.3.6 Chapter 8 - Evaluation of e-Chasqui in reducing errors
This chapter describes the cluster randomized controlled trial performed to evaluate the
effectiveness of e-Chasqui in reducing the number of communication errors compared to the
paper-based system. The trial was conducted in the same 78 health establishments in Peru.
However, here baseline data were collected every four months for 12 months before the health
center randomization and then for the same months the following year. Comparisons were made
between intervention and control districts and within-districts before and after the introduction of
the intervention.
It was found that the major sources of errors in the paper results are missing results or charts,
accounting for approximately 90% of all errors. When comparing the control and intervention
HCs, there was no difference in the error rate for either cultures (21.5 vs. 21.9%, p=0.07) or
DSTs (18.8 vs. 15.6%, p=0.26). However, when taking into account the online viewing of results
by the intervention HC personnel, there is a significant decrease in errors in both cultures (1.9 vs.
21.9%, p<0.001) and DSTs (1.4 vs. 15.6%, p<0.001). A majority of users responded that they
were missing at least 10% of results in the paper system (66% for control HCs, 55% for
intervention HCs) and approximately the same proportion felt that this diminished the
opportunity of treatment given to a patient. This showed that e-Chasqui reduced the number of
missing laboratory results at point-of-care healthcare sites via electronic viewing, while the rate
of missing results or errors on paper remained unchanged.
2 Background
This chapter provides the background on tuberculosis, the infectious disease targeted by these
informatics tools. It describes the electronic medical records (EMR), laboratory system, and data
collection systems implemented in developing countries and the evaluations that have been
performed on them. It also summarizes the major findings of evaluations of these three types of
systems in developed countries. The first section describes EMR implementations in developing
countries. The second section provides a systematic review of evaluations performed on EMRs,
laboratory information management systems (LIMS), and research or data collection systems
that have been implemented in developing countries. It shows that although there is a rising trend
in the number of evaluations performed, there are still few scientifically rigorous data on the
effectiveness and cost-effectiveness of these systems in developing countries. The third section
describes the evaluations of those systems in developed countries. In these settings, evaluations
of different methodologies have been performed and have been shown to reduce delays, decrease
errors, and positively impact patient care. Finally, the last section describes the Partners In
Health EMR (PIH-EMR) that has been used for treating multi-drug resistant tuberculosis (MDR-
TB) patients in Peru since 2001. Both the handheld and web-based systems described in this
dissertation were built on this platform.
2.1 Tuberculosis
Tuberculosis (TB) is a common infectious disease caused by mycobacteria, the most common of
which is Mycobacterium tuberculosis. In approximately 80% of cases, TB affects the lungs
(pulmonary TB), but it can also affect many other parts of the body (extra-pulmonary TB), such
as the central nervous system, gastrointestinal system, bones, or joints. The most common
symptoms of TB are a chronic cough lasting at least two weeks28 with or without blood, chest
pain, weight loss, fever, and night sweats. Extra-pulmonary TB can have a variety of other
symptoms depending on the organ affected.
Tuberculosis is spread through the air, when people who have the disease cough, sneeze, or spit.
It has been estimated that a person with active but untreated tuberculosis can infect 10-15 other
people per year. One third of the world's current population has been infected with M.
tuberculosis,29 however, most individuals will have an asymptomatic, latent infection. About one
in ten of these latent infections will eventually progress to active disease, which, if left untreated,
kills more than half of its victims. In 2004, mortality and morbidity statistics included 14.6
million chronic active cases, 8.9 million new cases, and 1.6 million deaths, mostly in developing
countries. 29
The :most common detection method for TB is smear microscopy because it is low cost, requires
little training, and the result can be read in the same day. It involves collecting a biological
sample (usually sputum or some other clinical material), fixing it thinly on a glass slide and then
staining it with a dye that binds specifically to mycobacteria (making them easier to identify
under a microscope).29 Another type of test with higher sensitivity and specificity is a culture.
There are different methods for cultures but all grow the mycobacteria in a liquid or solid
medium for 20-60 days, then detect growth by evaluating the sample by visual exam or other
modes of visualization to see if any mycobacteria can be detected. Both of these tests are used
both to detect TB and to monitor a patient on treatment.
There are strains of TB that have become resistant to anti-tuberculous medications. Multi-drug
resistant TB (MDR-TB) is TB resistant to the two most potent drugs, isoniazid and rifampicin.
Extensively drug-resistant TB is resistant to isoniazid and rifampin plus resistant to any
fluoroquinolone and at least one of three injectable second-line drugs (amikacin, kanamycin, or
capreomycin). 30 To diagnose the resistance pattern of any strain of TB, a drug susceptibility test
(DST) must be performed. Again, there are different methods, but the most commonly used in
developing countries grow the TB strain in a liquid or culture medium with some concentration
of the drug to be tested. Visual or automated detection then confirms if the strain grew in the
presence of the drug and if so the strain is considered resistant to that drug.
2.2 EMRs in Developing Countries
Developing countries provide a greater challenge in the implementation of EMR systems than
developed countries due to lower levels of infrastructure, communications and education.
Despite these additional challenges, EMRs in developing countries are becoming more widely
used, easier to implement, and more prominent in the public domain. Studies have shown the
increasing availability of internet in developing countries and its increased use by health care
professionals,3 1-34 including the use of email and digital images for telemedicine.3 5-3 9 A broad
range of robust and flexible devices are becoming available. 40 Governments are also becoming
more aware of the need to develop clinical and reporting information systems41 and to evaluate
their use in health care.42
Several EMRs have been implemented and successfully used in developing countries. I
conducted an exhaustive literature search in August 2006 to identify all published descriptions of
EMRs, including those that were not peer-reviewed or were presented in conference proceedings.
This search used a review of EMRs in developing countries43 as a start and was supplemented by
search of MEDLINE and Google Scholar using combinations of the terms: "electronic medical
record", "electronic health record", "electronic patient record", "developing countries", "third
world", "poor settings". We retrieved potentially relevant articles and reviewed their reference
lists for additional articles. Further, we consulted colleagues to identify further unpublished
systems. We restricted my search to only English articles.
* In Kenya, the Mosoriot Medical Record Systems (MMRS) has been implemented in a
primary care rural health center.44 6 The MMRS provides both patient registration and visit
data collection functions. Data are collected on all patients seen in the medical clinic,
including their laboratory test results and medications. Seven networked computers are
linked to a single MS Access@ database, which maintains information on over 60,000
patients.
* The Lilongwe EMR is a patient management information system for a wide range of clinical
problems in the pediatric department of a central hospital in Malawi.47 Data are collected on
patient demographics, medication, laboratory tests and X-rays by using touch screens.48 A
centralized server, located in the hospital, connects all of the touch screens. This system
contains information on over 160,000 patients.
* The Brazilian public health system uses the Computerized System for the Control of Drug
Logistics (Sistema de Controle Logistico de Medicamentos, SICLOM) to deliver
antiretroviral (ARV) treatments to over 100,000 patients. 49 50 This is by far the largest group
of HIV patients whose treatment is tracked by an EMR in the developing world. Information
about this system is limited; available literature indicates that the system registers the
distribution of ARVs, helping both to maintain needed stocks of the drugs at the national
administrative agency and to ensure that ARVs are prescribed in accordance with national
treatment and prescribing guidelines to maximize efficacy and minimize toxicity. A dial-up
connection allows physicians-who each have separate data bases on their desktops-to
periodically connect to the central server and update patient records. Another computer
system, called System for Control of Laboratory Exams (Sistema de Controle de Exames
Laboratoriais, SISCEL), established in 1997, gathers data from the public HIV laboratories
nationwide and sends the information, online, to the central AIDS administration in
Brasilia.50
* The MEDCAB system was implemented in an urban primary health care practice in
Cameroon.51 Data are collected on patient demographics, medication and laboratory tests.
The implementation team found that, after 14 months of usage, only 8 of the 16 users were
still using the system. The main reasons for attrition included: (1) trained personnel left the
practice; (2) changes in management, new leadership gave less attention to the project; (3)
continual hardware breakdown; and (4) departure of most of the main investigators.
* CAREWare is an EMR developed by the US Department of Health and Human Services to
support HIV treatment. It has over 350 US based sites and was deployed in Uganda in
October 2003.52 The MS Access@ stand-alone database provides comprehensive tools for
tracking HIV patients and their treatment, including clinical assessment, medications and
billing data. Currently, the system contains information on thousands of patients in the USA
and several hundred in their two sites in Uganda. An internet-accessible version has been
developed and deployed.53
* FUCHIA was developed by Epicentre, the epidemiology group of Medecins Sans Frontieres
(MSF), to support their HIV treatment projects. 54 It supports clinical care and long-term
follow-up of patients, including scheduling of visits; it includes data on medications and
investigations and generates reports. It was developed as a stand-alone system using MS
Access@ and the Delphi programming language. This system is reported to be used in
multiple sites where MSF provides care, although a list of sites was unavailable.
* An information system was developed to support the TB program in Botswana using Epilnfo,
a free stand-alone program from the US Centers for Disease Control and Prevention (CDC)
designed for data collection and analysis in developing countries. 55 56 This system was
implemented in five pilot projects in Botswana and South Africa which have 8,000 and
16,000 TB cases annually, respectively. However, no further data on its use was available.
* An MS Access@ based system was also used in Botswana to support that country's first
public highly active antiretroviral therapy (HAART) outpatient clinic. It used optical
character recognition (OCR) technology to scan three one-page data forms into the electronic
database. They used this system for seven months to manage about 3000 patients on
HAART and concluded that this OCR-based system combined ease of data entry and saving
of physician time while not disrupting the patient-physician encounter.57
* The Patient Record Information System (PaRIS) was built in Indonesia for primary health
centers spread over the thousands of islands which comprise the country.58 Data collected
include patient demographics, visit dates, medication, and disease category. The system uses
a radio modem to connect 5 computers to a Postgres SQL database server on Linux
machines. Each Linux machine has the database for local information as well as a copy of
the entire global database. No information on the actual usage of this system was available.
* A recent report40 includes other systems that have been implemented in developing countries
including Therapy Edge, 59 60 Care2x,61 and World Vista, however, no other implementation
information could be found aside from the list of countries where these systems have been
used.
* EMR systems are also being implemented in Zambia (national EMR using smart cards),62
Tanzania (MS Access@ database for PEPFAR project), Haiti (pilot phase of data entry and
reporting tool for PEPFAR and Global Fund reporting) and South Africa (use of cell phones
to monitor adherence for the management of HIV/AIDS in patients on antiretroviral
therapy).63 However, no further information could be found in the literature.
2.3 Evaluations of EMRs, LIMS, and Data Collection Systems in Developing
Countries
Despite the increasing number of EMR implementations in developing countries, no formal
evaluations have been published of their impact on patient outcomes or clinical care,22 24 64 and
only limited evaluations on their impact on improved productivity among health professionals
exist.65 -6 7 These evaluations are essential in ensuring that the systems being implemented are
safe, have a significant impact, and are not a waste of already scant resources. 66 68 A systematic
review performed in 2004 of the use of IT in primary health care worldwide 22 found that most
articles in the realm of eHealth "lacked any evaluation of their concrete application to health
care." This echoes the conclusions of a 2001 review of the impact of computers on primary care
titled "A descriptive feast but an evaluative famine,23" as well as separate systematic reviews of
telemedicine applications' effect on patient care69 and cost-effectiveness. 70
We performed a systematic review of evaluations of EMRs, LIMS, and data collection systems
in developing countries. 71 The goal of the review was to survey the evaluations that have been
performed on these types of systems in developing countries to find their potential impact and to
guide future implementations and evaluations of these systems.
2.3.1 Methods
2.3.1.1 Studies Eligible for Review
We included any qualitative or quantitative evaluation of EMR, LIMS, or data collection system
as described below in developing countries. Developing countries were defined as those in the
Emerging and Developing Economies List in the International Monetary Fund's World
Economic Outlook Report72 . Evaluations were excluded if (1) data completeness of the system
was the only outcome, (2) the evaluation method was not described in the article, (3) the article
was limited to describing the feasibility or technical evaluation of a system, (4) the evaluation
was on attitudes towards or knowledge of eHealth (not an implemented system), or (5) it was
only an educational tool 73 74. In the cases of Uganda Health Information Network75 76 and
EHAS 77 78 where both systems were a health education and an eHealth system, we only report on
the eHealth system.
2.3.1.2 Finding Relevant Studies
We conducted a worldwide review of the literature and requested submissions from researchers
and implementers of eHealth systems in developing countries. Literature searches were
completed through May 2008 without language restrictions through MEDLINE, EMBASE,
Science Citation Index (Web of Science), Social Sciences Citation Index, The Cochrane Library,
and the Latin American and Caribbean Health Science Literature Database (LILACS). To find
reports not in scientific journals or conferences, we also used Google Scholar. All citations were
downloaded into EndNote X (Thomson ISI Research-Soft, Philadelphia, PA). For MEDLINE
and EMBASE, terms were derived from the MeSH database and EMTREE tool, respectively.
Among the terms used in the final strategies were medical informatics applications, management
information systems, telemedicine, telehealth, reminder system, geographic information system,
hospital information systems, outcome and process assessment (Health Care), program
evaluation, evaluation studies, attitude, costs and cost analysis, developing countries, poverty,
Africa, Latin America, eastern Europe, central or southeastern Asia (complete strategies
available from the authors). An initial reviewer evaluated the eligibility of all studies identified
in our search. A second reviewer confirmed all relevant articles and retrieved the full text of each
article. Supplementary methods of finding evaluations included a review of article reference lists,
informatics conference proceedings, information provided by primary study authors, requesting
submissions from other researchers and implementers and searching the RHINO Literature
Database 79 and other recent reviews.22 43 80 81
2.3.1.3 Data Abstraction and Synthesis
We extracted data according to recurring themes. We summarized these findings using tabular
techniques and descriptive statistics. Reported analyses were too disparate to be pooled in a
meta-analysis.
The systems described in the articles were placed into one of three categories:
1. Electronic Medical Record (EMR): an electronic record of health-related information on an
individual that can be created, managed, or consulted by clinicians or staff. We have found
that in the literature the term electronic health record (EHR) is used interchangeably and
therefore will be used as a synonym for the purposes of this paper.
2. Laboratory Information Management System (LIMS): a system for laboratory specific
activities or for reporting results to administrators and health care personnel.
3. Research or Data Collection System: any electronic system used for collecting data from
different locations or for storing, managing, or reporting on data used for research purposes.
Evaluations were classified into two major categories: qualitative and quantitative. In this
review, qualitative evaluations were those where users, patients, or staff gave their opinion
regarding a system. These could take the form of questionnaires, focus groups, or interviews.
This definition is different from the one proposed by Strauss and Corbin of "any type of research
that produces findings not arrived at by statistical procedures or other means of quantification." 82
Quantitative evaluations were those whose outcomes were data quality, administrative changes,
patient care, or economic assessment. The evaluation designs were grouped according to the
definition by Friedman and Wyatt:83 (1) descriptive (uncontrolled) study; (2) historically
controlled (before-after) study; (3) case-control (retrospective) study; (4) prospective self-
controls (subjects performing same action in both systems);' (5) simultaneous nonrandomized
controls; (6) simultaneous randomized controls; and (7) externally and internally controlled
before-after study. Two cost studies 84 85 and two studies that modeled future medication
requirements86 87 were categorized as self-controls, since the authors compared the impact of the
system against the same situation without the system. Due to the inherent limitation of
performing a case-control, descriptive, or qualitative study without statistics, we will not
comment on the limitations of these studies in the results sections.
2.3.2 Results
Searches retrieved 1947 citations. Five of these articles were excluded because they did not have
abstracts and full text versions were not available. 88-92 After the initial screening of article titles
and abstracts, we found 154 articles that appeared relevant. An additional five articles were
identified by hand searching bibliographies of eligible articles and prior reviews. Of these, 22
were deemed to fulfill the inclusion criteria of the review after full review of their abstracts, and
are listed by type of system and evaluation in Table 2.1. For three of these articles, we were only
able to retrieve the abstract, but still included them in the analysis. 93-96 Brief descriptions of
outcomes and limitations are described under each category of system type in Tables 2.2-2.4.
Though it is not in a developing country, we included an evaluation from the Indian Health
Services in the U.S. since conditions were similar to those in developing countries.97 If a system
had multiple evaluations, only those with different outcomes are listed. If they had the same
outcome, we took the one with the largest sample size. There were two articles reporting that an
1 This category was added by the authors
evaluation did not occur because of a failed system implementation.24 98 These are not part of the
results, but we considered it relevant to list them since articles on unsuccessful systems are not
commonly published.
Eight articles performed qualitative evaluations and 18 performed quantitative evaluations. If an
evaluation performed both types it was counted in both categories. Two qualitative and six
quantitative evaluations performed some sort of statistical analysis on the results. Of all these
evaluations, two of the qualitative and two of the quantitative were performed by an outside
evaluator that was not the system developer. The number of evaluations has increased in the last
few years.
Table 2.1 Number of total articles for the different eHealth categories by type of evaluation. If an article had both
qualitative and quantitative studies or multiple types of systems, it was counted in both categories. Numbers are
quantity of studies (percentage of total studies)
eHealth Category Qualitative Quantitative
Descriptive Controlled
Studies Studies
Electronic Medical Record (EMR) 4 (14) 1 (3) 4 (14)
Laboratory Information Management Systems (LIMS) 0 1 (3) 3 (10)
Research or Data Collection Systems 4 (14) 1 (3) 11 (38)
TOTAL 8 (28) 3 (10) 18 (62)
2.3.2.1 Electronic Medical Record (EMR)
EMRs are the core application on which other clinical systems such as computerized clinical
decision support (CDSS), computerized order entry (COE), and sometimes telemedicine systems
can be implemented and sustained. Because of this they usually need to encompass a variety of
different functionality, making their implementations complex"99 and often prone to failure. 100
This complexity provides an additional challenge in evaluating these systems. In our search we
were only able to find one evaluation that had a control group (Table 2.2); four were qualitative,
with only one of them using statistics; two were case-control studies that could provide an
insight into possible impacts, but had limited scientific rigor. 83
The Vista system used by the Indian Health Services (IHS) was the most complete system, as it
includes services for clinical reminders, radiology order entry, medication order entry, and lab
order entry. Several of the other EMRs also incorporated multiple services,44 101 102 however all
of them will only be reported in the EMR sections because none performed evaluations on the
separate parts of the system.
The MMRS evaluation provided data on the impact that an EMR could have on improving staff
productivity and reducing patient wait times. The other evaluations gave insights into the ability
of EMRs to improve staff satisfaction, providing higher quality data to relevant personnel, and
ultimately improving the care provided to patients.
Table 2.2 Description of EMR evaluations in increasing order of evaluation strength with multiple evaluations of a
single system placed together
System or Evaluation
Institution Type Outcome
Their system cost $750 dollars total for satellite communication for 2700 patients
PDA-EHR0 3  Cost and a one-time fixed cost of a satellite phone ($500 plus monthly fees).
Over 4 years immunizations increased from 45.4% to 81.9% and 46.1% to 77.7%
Case-control in DPT and polio vaccines; antenatal registration increased from 384 to 705
MCHS 0 4  study patients.
Nutrition Decreased percentages of wrong entries and non-entries either of weight or height
Support- Case-control (p<0.05); Increases seen in nutrition support services (p<0.05); referrals to clinical
Philippines'" study dietitians (p<0.05), and dietician productivity (p<0.05).
Staff & patient Increased staff productivity and satisfaction. Did not increase staff persuasion and
HMIS-Korea'0 2  surveys decision abilities. Increased visitors' satisfaction with services
Advantages: Physicians recorded improved communication (95%); improved
quality care (85%); accurate entry and retrieval of data (80%); easy access to data
(70%); usable in physician liability cases (64%); reduced medical errors (67%);
enhanced productivity (59%).
Physician Disadvantages: disease coding was a problem (70%); system was time
Oman-EMR 0  survey consuming to use (67% agree); and too slow (60%).
Advantages: EHR implementation was viewed positively (66%); improved
quality of care (35%); 34% self-reported that EHRs improve quality, this was
associated with increased utilization (odds ratio 3.03, 95% confidence interval
Physician 1.05- 8.8). IT could improve quality of care in underserved settings (87%)
IHS-Vista97  survey Disadvantages: decreased quality of patient-doctor interaction (39%).
Hospital matron noticed a cluster of sexually transmitted disease and therefore
dispatched a team to investigate. Also noted lack of child immunizations therefore
dispatched nurses to that site. Reports that previously took a clerk two weeks, now
MMRS44  User opinion takes minutes; allowed the director to reassign two clerks to other duties.
Duration of visits dropped from 41 to 31 minutes; providers time with patients
dropped by half, from a third to a sixth of their workday (p = 0.004); providers
spent two thirds less time interacting with other staff (p = 0.0002) and tripled their
time spent in personal activities (p = 0.001); clerks spent two thirds less time
MMRS44  Before-after interacting with other staff and almost doubled their time registering patients.
2.3.2.2 Laboratory Information Management Systems (LIMS)
There were only three evaluations of LIMS, of which only one had a control group. However
they suggest two major benefits that a LIMS system can provide: (1) decreasing turn around
times in the communication of results and (2) improving productivity of the laboratory. An
additional impact, reduction in errors, has not yet been studied.
Table 2.3 Description of LIMS evaluations in increasing order of evaluation strength
System or
Institution Evaluation Type Outcome
Cholera was isolated in 22.6% (7/31) of samples sent to a central laboratory.
Information was relayed to hospital and health authorities, who took strict
measures to improve hygiene at a festival. Subsequently, the number of
SGPGIMS 93  Descriptive diarrhea cases during festival decreased and an epidemic was averted.
Productivity indexes showed an increase by 41% in number of patients
Tesilab1'O Case-control study handled and 28% in number of tests processed.
Turn around times for routine samples decreased from 1 to half day; number
of samples processed increased a factor of 2; annual laboratory revenue
VPN-LIS'0 7  Before-after increased 4 times, from 55,000 to 220,000 euro per month.
2.3.2.3 Research or Data Collection Systems
Research or data collection systems had a large number of evaluations. All of these systems were
on PDAs or used PDAs as the point of contact with the user and then had a back end database to
collect and store data. Four RCTs showed that the main benefits of PDA systems were: data
quality similar to paper systems 8 109 or higher, 25 110 less time to perform interviews, 110 and
decreased data collection time.25 Two of the RCTs compared the PDA system to paper, but not
to a gold standard, 10 8 109 one had a small number of users (n=4), 25 and one was performed 17
years ago.
All three evaluations that had user surveys reported that users preferred the PDA system over
traditional paper, two reported that users could fix most technical problems with the device,
though technical support is still a critical need. Further, the organizations that implemented the
PDA systems in Uganda75 76 and South Africao0 9 had experience with hundreds of users and over
a dozen implementations combined, which empirically suggests the feasibility of these systems.
The cost-analyses showed that these systems were able to recuperate their high initial costs by
providing increased efficiency and continuous material costs. The Uganda system 75 76 showed a
cost savings of 91% over the paper system. The South African analysis10 9 calculated that after
using the PDA system for data collection in eight studies of medium scale, the system would
equal the costs of paper. The system in Lima, Peru 25 would pay for its original development and
implementation in 5.5 years, and for expansion to other health districts in 3 months.
Table 2.4 Description of research or data collection system evaluations
System or Evaluation
Institution Type Outcome
Collected data on 83,346 individuals over seven weeks with no PDA
PDA-Tanzania"' Descriptive problems. Dataset was available within 24 hours. Median time to form
completion was 14 minutes during training and nine minutes during survey.
87% reported that health content received helped them make faster more
Uganda Health accurate diagnoses. 86% integrated PDA into other activities. 73% able to
Information solve problems; 68% reported problems to health unit with only 41% of them
Network75 76  User survey being answered.
System provides up to 91% saving per unit spending compared to paper-
Uganda Health based HMIS data collection and reporting approaches. Reporting compliance
Information to MOH improved from national average of 63% to 94-100% for districts
Network 75 76  Cost analysis using UHIN.
Advantages: Time savings (95 percent); the ability to quickly mobilize or
organize individuals (91 percent); reaching audiences previously difficult or
UN-Vodafone impossible to reach (74 percent); transmit data more quickly and accurately
Partnership 67  User survey (67 percent); gather data more quickly and accurately (59 percent).
Rate of discrepant entries was 1.7%. Categorical data were more commonly
discrepant than were continuous "typed in" data (2.4% versus 1.2%; p=
PDA-Gabon 12  Self-controls 0.001).
In 558 patient interviews accuracy of PDA and paper methods was 97.1% and
97.6%, respectively. For 1,543 field visits, accuracy rate for PDA and paper
PDCS-Nicaragua 3  Self-controls methods was 98.9% and 99.3%, respectively.
Before-after First survey, almost perfect agreement between paper and PDA. Second
(first survey), survey, rates of responses to sensitive questions were similar between both
RCT (second kinds of questionnaires. PDA had 96% less inconsistencies (p = 0.0001) and
PDA-PREVEN 10 8  survey) 66% less missing values (p = 0.001) than paper.
There was no difference between participants' self-reported comfort across
handheld and paper conditions. However, participants in the handheld
HIV-PDA condition were more likely to give socially desirable responses to the sexual
interview system'1 4  Block RCT behavior questions (p<0.01).
Cost of PDA survey is slightly less than paper when cost of hardware is
annualized over four studies and the programming cost excluded. When
programming cost is included, upfront costs need to be discounted over eight
PDACTo9  Cost analysis studies to obtain a comparative cost with paper.
85% of PDA users preferred PDA and 7% preferred paper for answering
questions about sex. 53% of paper users preferred PDA and 28% preferred
PDACTo9  User surveys paper.
Simultaneous
randomized Intra-scale reliability and the test-retest reliability were found to be adequate
PDACT1o9  controls and similar between paper and PDAs.
User satisfaction higher for PDA (mean 5 of 5) than paper (3.5 of 5). PDA
reduced mean work-time per result from 6.75 to less than 2 minutes. Mean
1.13 technical problems per month which could be fixed in the field (2 users)
PIH-EMR PDA2 6  User Survey or back at the office (2 users).
Work hours required decreased by 60% (p<0.001). Total cost and time to
develop and implement was US$26,092 and 22 weeks. Cost to expand to 9
PIH-EMR PDA26  Cost analysis districts was $1,125 and to implement collecting patient weights $4,107.
PDA-based system had a processing time of 6.2 days, significantly lower than
both the baseline and control site measurements of 54.8 and 64.4 days,
PIH-EMR PDA25  Cluster RCT respectively (p<0.0001). Reduced errors from 10.1% to 2.8%.
Handheld showed a 30% improvement for collection of identification data
Cross-over and a 100% improvement for dates and times [system automatically time
simultaneous stamped]. Significant reduction in inter-individual variability in data
randomized accuracy. By the third week the average interview times were 31% shorter for
PDA-Gambia 1 o controls field workers who used handheld (p=0.007).
2.3.3 Discussion
This review shows that, with the exception of PDA data collection, there are still few
scientifically rigorous data on the effectiveness and cost-effectiveness of these types of systems
in developing countries.
These initial evaluations suggest that the following functions show a positive impact in
developing countries:
1. Tools to decrease communication times of information within and between institutions.
2. Collection of clinical or research data using PDA.
3. Reductions in errors in laboratory and clinical data.
Evaluations of EMRs, LIMS, and data collection systems are challenging and require significant
resources in addition to the creation and implementation of the system itself. Implementation
should have evaluations built into the implementation process. This may provide useful
feedback to improve the project and may also demonstrate the impact of the system.
There are benefits of electronic systems that are difficult to quantify. One is the ability to
perform operational research with greatly reduced costs. During our search we found several
articles that used electronic databases and probably could not have been performed if manual
data collection were required. 1 15- 122 Another benefit is the increase in communication across
large distances of emergency data such as in a cholera outbreak 93 or refugee situations. 123
However, more robust and better-evaluated information systems are going to be necessary to
overcome the additional implementation challenges in developing countries. These systems must
be evaluated to ensure that they are safe, effective, and have a reasonable cost. When looking at
the software systems included in PEPFAR's ART Software Inventory Report 124 and
EngenderHealth-OpenSociety software tools 125 126 comparison, only three systems, the PIH-
EMR/HIV-EMR, MMRS and Vista, had any evaluations performed.
2.3.3.1 Challenges and biases in evaluating medical information systems
Carrying out successful evaluations of medical information systems is challenging in any
environment as there are many factors that influence a system's effectiveness. Determining if an
improvement in data quality or clinical care is due to an information system requires carefully
controlling for potential biases and confounders.83 Historical controls (before and after studies)
can be hard to interpret as healthcare delivery changes rapidly and improvements are often due to
other' factors. Studies with prospective control groups address this problem, but it is important to
ensure the groups are equivalent. Selecting the appropriate unit of analysis can also be
challenging, as it may not be appropriate to randomize the use of the system for some patients
and not others in the same clinic, both from a practical and ethical stand point, and because there
may be carry over benefits from the information system such as better access to information or
laboratory data. Randomizing by clinic or hospital may be a better approach (cluster
randomization), the main challenge being the need to include multiple clinics to have an
adequate sample size. One pragmatic and fairly robust strategy for quantitative studies is to
carry out before and after comparisons in the intervention sites and also include contemporary
controls. This can be accomplished in a staged intervention where some clinics are randomized
to get the system before the others.
26 127
Another important potential bias is the "Hawthorne effect" where staff are aware that they are
being monitored and therefore behave differently. This is particularly a problem if the
intervention sites are aware they are being studied but the control sites are not. A related issue is
when additional resources are invested in the intervention site such as training or better
infrastructure. These biases can be minimized by treating the intervention and control sites as
similarly as possible and just varying the information system or one of its components.
Both the software system implemented and the implementation process are extremely important
in determining the impact that the system will have on clinical and administrative processes.
Further, the system and implementation process used become even more critical as EMR systems
begin to encompass more processes and users, or if the organizations adopting them grow in
scale. In such cases, implementing systems that have been evaluated and shown to work in
similar conditions can provide an initial, secure foundation.
For evaluations of information systems in resource poor environments all of the above issues
need to be taken into account, as well as factors specific to the environment and staffing.
Deploying an information system in a country like Haiti or Kenya first requires an assessment of
the feasibility and sustainability of running PCs and/or servers in the location and the ability to
provide technical support and training. A simple and important test is if the system is still
functional and in use one and three years after implementation. Measures of system usage and
data completeness are also necessary both as an end in themselves and as an important
prerequisite to a full evaluation study, otherwise a great deal of time and effort can be wasted.
It is clear from the evaluations reviewed here that none met all the criteria described above.
However the system for drug order entry in Peru128 was re-studied three years after
implementation and was still in use and functional, generating warning alerts for 5.3% of
medication orders. The Satellife75 and On Cue Compliance Service 29 were shown to be well
liked by users several years after implementation and, perhaps more importantly, by an
independent evaluation team. The strongest evidence for beneficial impact of these systems on
healthcare will come from long-term follow-up carried out by independent evaluators.
2.4 Evaluations of Electronic Laboratory Reporting Systems and Handheld
Systems in Developed Countries
2.4.2 Electronic Laboratory Reporting Systems
Information systems have affected the manner in which laboratory data are handled,
communicated and reported for over two decades and will continue to play a larger role in the
future. The need to enhance communication between US health organizations was the impetus
for the CDC's development of the Public Health Laboratory Information Systems (PHLIS)30 , a
system still used both domestically and internationally. In the US, several state and local health
departments have already made the transition to web-based electronic laboratory reporting and
most will have such a system in the next 5-10 years.131
Even with this extent of adoption, the prompt and accurate reporting of laboratory test results,
and the use of laboratory information systems and communication between all partners continue
to challenge health care systems. Recent work has shown unresolved problems with data
transmission, data completeness and accuracy, and user interpretation. 132-134 Furthermore, the
CDC's National Plan for Tuberculosis Laboratory Services includes these data-related issues
among the top five challenges to the development of an integrated national system that can
ensure prompt and reliable information flow among laboratory staff, clinicians, and TB-control
officials. 35
Integration of electronic laboratory-based reporting software has been shown to decrease
communication time136-139 and to increase the completeness of reporting.' 36 138 139 These benefits
have been shown in both non-randomized, prospective cohort (before and after) 136 and
retrospective cohort studies that compare a paper based and an electronic system.
138 139
Studies have also shown that such data can be used to warn doctors about important and urgent
interventions. 140-145 The evaluation methodologies for these studies are varied. They include
non-randomized, prospective cohort (before and after), 141 144 retrospective cohort, 145 prospective
time-series,"43 and randomized controlled trials. 142 The benefits of these alerts include:
1. More clinicians ordering appropriate tests for their patients,14
1  145
2. Decreases in the time until an appropriate treatment is ordered for patients who had critical
laboratory results, 14 0 142 143
3. Improved functional tests performance by patients after a specified time,
143 144
4. Fewer follow-up visits by patients. 145
To date, there have been no studies of the impact of access to laboratory data in an EMR system
on the quality of care provided to patients in developing countries.
2.4.2 Handheld Systems for Data Collection
The use of portable handheld computers, or personal digital assistants (PDA), in health care and
clinical research is on the rise, with a corresponding increase in publications.'14 147 A review of
sixty-seven studies found that approximately 60% to 70% of medical students and residents use
PDAs for educational purposes or patient care.' 48 Their use has been described in numerous
149-153
research and clinical settings with a variety of uses including patient self-monitoring4953
patient assessment154-157 and field data collection.
158-161
Many of these studies have shown that handheld technology has several advantages over
traditional paper modes of data capture. These include, but are not limited to:
1. data accuracy,
2. timeliness of data capture,
3. decreased time to fill out forms and adherence to protocols for data collection.
The evaluation methodologies have been varied including non-randomized, prospective cohort
(before and after) and prospective cohort studies between a paper based and an electronic
system,152-155 161 and descriptive studies. 149 150 158 160 Also, several studies have been controlled
studies where the same user performs the same task in both the paper and electronic form, with
the order being decided in a random fashion.' 54 156 159
A review of 9 randomized controlled trials found that results favored handheld computers over
paper for data collection among study participants, but the data are not uniform for the different
outcomes. Handheld computers appeared superior in timeliness of receipt and data handling
(four of four studies) and were preferred by most subjects (three of four studies). On the other
hand, only one of the trials adequately compared adherence to instructions for recording and
submission of data (handheld computers were superior), and comparisons of accuracy were
inconsistent between five studies.' 46
2.5 The Partners In Health EMR (PIH-EMR) for sensitive & multi-drug
resistant TB (MDR-TB)
Partners In Health (PIH), a 501(c) (3) nonprofit corporation was founded in 1987, two years after
PIH co-founders established the Clinique Bon Sauveur in Haiti. It is linked with the Department
of Social Medicine at Harvard Medical School and the Division of Social Medicine and Health
Inequalities at the Brigham and Women's Hospital. They share PIH's mission to provide a
preferential option for the poor in health care. By establishing long-term relationships with sister
organizations based in settings of poverty, Partners In Health strives to achieve two overarching
goals: to bring the benefits of modern medical science to those most in need of them and to serve
as an antidote to despair. PIH has sister organizations in Haiti, Peru, Russia, Mexico, Guatemala,
Malawi, Lesotho, and Rwanda which provide patient care, develop innovative approaches to the
management of chronic diseases in developing countries and, in some cases, build and run
clinics. PIH also has expertise in the procurement of drugs and other essential supplies, shipping
and pharmacy management. PIH has a team with extensive experience of management and
finances and had a turn over of over $30 million in 2006.
In 1996, Partners In Health (PIH), with sister organization Socios En Salud (SES) in Lima and
the Peruvian Ministry of Health (MINSA), created a pioneering treatment program for multi-
drug resistant tuberculosis (MDR-TB) to complement DOTS. They showed that it is not only
possible to treat such complex chronic diseases in developing countries, but cure rates can be as
good as those achieved in the US. In 2005, treatment outcomes continue to be excellent with 77
percent of patients with fewer than two previous treatments cured of their MDR-TB. The
remarkable successes in confronting an epidemic of multidrug-resistant tuberculosis in the slums
of Lima have instigated major changes in global health policies.
In 2000, SES and MINSA became the hub of a multinational TB treatment project funded by the
Bill & Melinda Gates Foundation. New support from the Global Fund to Fight AIDS,
Tuberculosis, and Malaria since 2003 has enabled SES and MINSA to expand the cooperative
treatment efforts and provide technical support to other countries starting similar programs.
The Partners In Health Electronic Medical Record (PIH-EMR) was developed within this project
and is unique in providing a broad range of functions to support high quality patient care for
sensitive and multi-drug resistant TB (MDR-TB) in a resource-poor setting. Functions include:
(1) an electronic patient registry currently maintaining information for over 13,800 patients; (2) a
web--based medication order entry system that has been shown to significantly reduce error rates
and work load,162 (3) a method for electronically archiving and displaying chest radiographs,37 163
(4) tools for generating monthly reports for funders; and (5) tools to predict future drug
requirements.' 64 This system includes a substantial set of data entry and analysis functions for
laboratory results including sputum smears, cultures, and Drug Sensitivity Tests (DSTs). The
PIH-.EMR can alert clinicians to abnormal laboratory results either when they log into the
system, on specially formatted patient reports, or by email. The PIH-EMR has been integrated
into the clinical and administrative workflow of Socios En Salud (SES), PIH's Peruvian sister
organization. The Tropical Disease Foundation, a Non Governmental Organization in the
Philippines, is also using the system to support the treatment of TB and MDR-TB in that country.
A second version of the system, the HIV-EMR, was deployed in rural Haiti in 2003 and in
Rwanda in 2005 to support the treatment of HIV/AIDS. 165 166 An offline component was
developed to overcome unreliable internet communications in some sites. This component
allows data entry and case viewing when the network is down and has proven reliable and
popular with clinical staff. The HIV-EMR's important role in the management of over 4,200
patients on ARVs shows the feasibility of implementing a medical record system in remote
clinics with virtually no infrastructure and limited technical expertise.
Other projects have shown that it is possible to create and deploy simple medical record systems
in developing countries.44 47 51 However, the PIH-EMR is unique in deploying its web-based
design in very resource-poor regions, including extensive use of communications tools and alerts
to track patient care in near real time.43
3 Development and Implementation of a PDA-based
Bacteriology Collection System
The following sections detail the development and implementation of a PDA-based system to
collect TB bacteriological data from over 100 health centers and laboratories in Lima, Peru,
process them, and enter them into the PIH-EMR. Section 3.1, Organization and Collection
Workflow, describing the institution adopting the technology and the initial workflow associated
with collecting results. Section 3.2, System Description, details the technology used and the full
system that was implemented. Sections 3.3 and 3.4, Results and Discussion, detail the
implementation results and lessons learned from this project.
3.1 Organization and Collection Workflow
As mentioned in Section 2.5, Partners In Health and sister organization Socios En Salud (SES)
provide treatment for thousands of MDR-TB patients. To monitor these patients, there exists a
bacteriology team within SES that collects all results for those patients.
3.1.1 Bacteriology Collection Team at Socios En Salud
All patients on MDR-TB treatment must leave a biological sample every month at their local
health center. Timeliness and accuracy of reporting results for these samples is essential to
determine if the patient is responding to treatment and, if not, to change the medications being
given' 67. This monitoring should result in shorter culture-conversion times, better treatment
outcomes, and prevention of further transmission.
We surveyed the work flow performed by the bacteriology collection (BC) team and found two
models of collecting information (Figure 3.1): (1) Single site model, where a patient's sample is
processed for smear and culture at the same laboratory and therefore the BC team member is able
to collect both results from one regional laboratory; (2) Dual site model, where a smear
microscopy test is performed at the local health center. The sample, with the smear result, is
then sent to the regional laboratory for a culture. A BC team member collects the primary smear
result from the local health center. He/she then visits the regional laboratory and collects the
culture result performed at the laboratory and also the result of the smear performed at the health
center (secondary smear information). This secondary smear information is cross-checked with
the primary smear information obtained at the health center to ensure correct communication
between the institutions.
Entered by hand
Culture
Results
- - Syhroiz in o
Synchronizatn in office
Health Centers without Labs (560)
Figure 3.1 Bacteriology team's workflow with the paper and PDA-based systems
The four-member BC team visits approximately 100 of these health centers and 5 regional
laboratories that care for MDR-TB patients and copy these results onto collection sheets (Figure
3.2). These sheets are then brought to the office, where the culture and smear results are verified
for correctness. The information is then copied to a monthly patient follow-up for clinical
purposes (Figure 3.3) and a second administrative form, and then typed into the PIH-EMR168 , a
web-based electronic medical record system. For Lima, the team makes at least bi-weekly visits
to all 105 sites distributed over 2,672 km2. At the time of this study many of these laboratories
and health centers did not have internet and an appropriate web-based laboratory information
system did not exit. Because of this, a PDA-based system was the most appropriate technological
solution.
Figure 3.2 Example ot a collection sneet tor iacteriology team
121
HOJA DE SEGUIMIENTO DE CULTIVO MENSUAL DEL PACIENTE
CON TSMDR PULMONAR EN TRATAMIENTO
MINDIVJDALiADO TS-PLUS
7tmaneaks- -------si ua
C rSA d :.......... .... ...... 
FchadeviooataS ....... u p
Cugue *l.i ...l . Leido a los: .... f... . . Reg.: .................. h....... .F : .. -....
CULTIVO
W FECHA auLTADO mA.w auS WN DIAS
40 -A3
1 7
24 I _ ' . (-V 
,  0 6 346 0 I
o- vas V3g F- C.s I p 4 7 )
2 t 11 + * OS (04 - . -C1 f to 0wa $ 34r
24 rI $ +  +  .| I + + I+ ljl
2+ O+ 
+
e$ (1+ p.+.+s +x .....
O+ +.pl ++ q12++:  .,. .+.+,,
Figure 3.3 Example of a monthly patient follow-up form that bacteriology team filled out in the offttice
The major disadvantages of this paper-based method are the delays in processing and entering a
result, data quality issues, and the heavy work load involved in the process. A preliminary study
found that the mean time from the test result date to entry in the PIH-EMR was 55.3 days. A
routine quality control examination found error rates as high as 10.1%, and the bacteriology team
was consistently backlogged with entry because of the increasing number of patients.
3.2 PDA-based System Description
To decrease delay time and errors, we designed and implemented an electronic bacteriology
collection system using a PDA as the initial point of data entry at the clinical site25. The
information is uploaded to the web-based PIH-EMR, where additional pages were created to
automate the validation of the data, generation of the required forms, and data transfer into the
PIH-EMR (Figure 3.4).
Lab Data
Patient Data
Sy ncPc)
Palm Pilot
PIH-EMR
Processing Section
MI
l81tt P" Dye (4 0"): 
I
i~fR ,e im , mid [ t earamis.
I I
Processing & 
Verification 
I
I 
I
I
; ,I
I
Final Bacteriology Section
1 MW 1 1 1 1 1 l 1 1 1 l 1 i
Figure 3.4 Overview of PDA-based system
3.2.1 Hardware and Software Selection
In selecting handheld computers, we compared Palm OS-based systems and Pocket PCs. We
chose the low-end Palm OS-based systems (Zire 31, Zire 21, and Z22) due to their lower cost,
smaller size and monochrome screens. In the poor areas where the bacteriology team collects
their information, discretion is important. The Palms' smaller size made them easier to disguise
within a notebook carried by the user and the monochrome screen called less attention.
In selecting software to use, we wanted to be able to do rapid prototyping of forms and be able to
connect to the Oracle@ database of the PIH-EMR. For these reasons we chose Pendragon®
Forms, a commercial application that applies a modified client/server model to the PDA/PC
relationship. It is based on a Microsoft Access@ database on the PC and has the ability to
"hotsync" to any Open Database Connectivity (ODBC)-compliant database. This system allowed
us to quickly create forms for entering bacteriology data, as well as to download patient
information and to upload completed bacteriology results to the web-based PIH-EMR using
Microsoft Access@ ODBC connection over the Internet.
3.2.2 PDA Forms
This bacteriology collection system was designed, developed, and tested with the BC team who
had experience in collecting bacteriology results from all over Lima, Peru. At every step of
development, we considered the current workflow and the role that an electronic system with
decision support could have. The PDA forms were created to follow the workflow. Therefore
two forms were created. The first was only for smear data (Figure 3.5a) which was used only if
the smear was performed at the health center (dual site model). The second form was for both
smear and culture data (Figure 3.5b) which was used at the reference laboratory in both the
single and dual site models.
Figure 3.b (a) mrnear and (b) culture result collection torms on thle F)IA
We also found that the users had to carry a list of all patients on MDR-TB treatment to ensure
that they searched for their monthly results. To eliminate the need for this list and to speed up the
process of data entry we placed the list of all of these patients from the PIH-EMR on the
collection form. This way the user could search for the name and on selecting a patient, their
health district and center would be filled in automatically on the form.
The initial PDA forms had the same data as the paper forms that the BC team was using.
However, as they discovered the ease of data entry, the leaders of the BC team requested that
additional data fields such as the laboratory where the culture was performed and the type of
specimen sent be added to the forms.
3.2.3 Decision Support System for BC Team in PIH-EMR
A module was added to the PIH-EMR which permitted the automated processing of data before
transferring to the bacteriology section of the PIH-EMR for clinical and administrative use
(Figure 3.6). This module included web pages which display information in a tabular format
identical to the previous paper forms. They were created taking into account the workflow of the
bacteriology team of data collection, verification of data, printing of additional forms and finally
entry into the PIH-EMR. The pages were designed to decrease the time required to verify and
enter data into the EMR as well as to improve data quality through decision support. Individual
pages were created for each of the following requirements:
1. View smears results in a manner similar to the current paper form
2. View culture results and their respective smear result in a manner similar to the current paper
form
3. Show errors and warnings for the entered data
4. Edit the entered data
5. Print forms for data that have been verified
6. Transfer the verified data to the bacteriology section of the PIH-EMR
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Figure 3.6 Main page of bacteriology module in PIH-EMR for bacteriology team to process results before
transferring them to clinical pages of the PIH-EMR
The web page that allowed users to view all of the information in a table format identical to their
previous forms can be seen in Figure 3.7. We found that these users, with low to moderate
computer experience, preferred this view because (1) it allowed them to see all of the
information at once, and (2) it was in a familiar format.
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Figure 3.7 Table view of all culture and respective smears entered through the PDA-based system
The next web page performs data quality checks previously done by the team (Figure 3.8). They
include:
1. Not allowing duplicate entry of a test result
2. Reporting any missing data for a specimen (first error in Figure 3.8)
3. In the dual site model, verifying that the primary and secondary smear information is
identical
4. Checking that every culture has a corresponding smear and every smear a corresponding
culture (second error in Figure 3.8)
5. Alerting for any overdue smear or culture that had not been transferred
6. Informing if a patient from a dual site institution is missing a smear from their health center
7. Color coding smears in the two site model to display if the smear information has been
collected from both sites and cross-checked
Errors Table
Smears Past Due (14 Days)
PIRID Name
12617
Cultures Past Due (70 Days)
PIH ID Name
13332
Errors and Warnings
ID Name SID
Sample Date Site Sample ID ResuIt and Strength District Health Center Entry 
Date
Palm
S15-Dec-2005 sputum 3843 Negative LimaCiudad C.S. Primavera 20-Feb-2006
Sample Date Site Sample ID Result and Strength District Health Center Entry DatePalm
I27-Dec-05 12687 Negative Lima EsteP.S. Los Geranios 15-Mar-2006
ample Smear Smear Result and Culture Start Culture Result
Date ID Strength Date ID Date
Smear with no culture
12617 22-Dec-2005 3843 Negative
Figure 3.8 PDA-based system's decision support page in the PIH-EMR
Subsequently, the users print selected results on a standard layout and then transfer all the results
to the bacteriology section of the PIH-EMR for clinical and administrative use (Figure 3.9).
These web pages were color-coded depending on the test performed, whether the information
had been cross-checked and whether there were remaining errors. If the data quality page detects
an error or missing information in the result, it is displayed in gray and cannot be transferred.
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Figure 3.9 PDA-based system's transfer page to the clinical section of the PIH-EMR
3.2.4 Additional Utilities
In the PIH-EMR, the bacteriology pages were modified to display which smear and culture
results were entered through the PDA-based system. Figure 3.10 below shows the PIH-EMR's
bacteriology page with several smear and cultures results marked as [palm] if they were entered
by the PDA-based system.
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Figure 3.10 Bacteriology page of PIH-EMR showing results entered by PDA-based system marked with [palm] to
the left of the sample ID (example marked with a red arrow).
Also, the leaders of the BC team had to report the number of MDR-TB patients who hadn't left
their monthly sample so an additional page was implemented to facilitate this task, which
showed patients who had or did not have a smear or culture result for the time period specified
by the user (Figure 3.11).
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Figure 3.11 Page to generate a list of patients who have or don't have a result for the time period chosen by the user.
The options on this page are to choose a health district (DISA) or any subdivision (Subdivision Actual), to exclude
any subsection (Excluir subdivision actual), to choose the specific date range (Fecha de BK), show those patients
who have left a sample (Mostrar los pacientes que han dejado una muestra?), and the type of test result either smear
or culture (Tipo de Prueba)
3.3 Results
This system was implemented initially in September, 2004. Over the next twelve months, the
system was piloted and iteratively improved for one year before a cluster randomized controlled
trial and a time-motion study began.
Training for the use of this system consisted of the development of a user guide and four training
sessions with the users of approximately four hours each. These sessions included training the
team on the use of the PDA and web pages, as well as feedback to improve the system. The
training time for new users should be considerably less. Further, there was frequent email and
text messaging contact between the developer and users during the entire development and
implementation periods. The frequency of contact decreased during the study period, once the
system had been completed.
The user response to the electronic system was positive, although the team was initially
apprehensive about its use. After 2-5 days, each of the users became comfortable with using the
handheld to enter information and found that approximately the same time was required to enter
information into the PDA as in the paper system. However, their most favorable response came
from being able to quickly verify and transfer the bacteriology results electronically instead of
having to work with large amounts of papers. Because of their experience the four users have
asked to expand the system to all five health districts in Lima as soon as possible.
3.4 Discussion
Many organizations, especially in developing countries, must collect information about specific
populations from a wide area. Handheld systems offer an advantage in being a portable method
to digitize information at the initial point of contact and initial experiences have begun to show
in what circumstances they are beneficial 75 169-171. In developed countries, it has been shown that
in clinical settings, handhelds have the potential to increase communication and reduce the
number of discrepancies 172 - 175. However, there are few studies of handheld implementation in
developing countries, and almost none of their impact in these locations, where the potential for
improvement is much larger than in developed countries.
This PDA-based laboratory result collection system allows users to gather results from many
distinct health establishments and later synchronize them to a central database, to verify all the
information and to transfer it to an electronic medical record system. Our hope is that the
development of our PDA-based system will help others implement similar systems. We have
come into contact with many organizations and researchers with similar requirements for
collecting data from multiple sources in different locations. We feel that one of the key factors to
success was the careful study of workflow, and the close relationship between the developers and
end-users.
4 Evaluation of PDA-based System
This chapter describes the cluster randomized controlled trial performed on the PDA-based
system and its results showing the system's impact. The first section describes the need for
evaluations of systems for remote data collection in developing countries. The Methods section
describes the methodology used for the study, the parameters studied, and the statistical methods
used for this analysis. We then show how the PDA-based system was able to significantly
reduce processing times and errors, as well as to be preferred by the users over the current paper
system. Finally, we discuss the implications of this evaluation and conclude that a well-designed
PDA-based system to collect data from institutions over a large, resource-poor area can
significantly reduce delays, errors, and person-hours spent processing data.
4.1 Introduction
Clinical and research organizations often must collect data from large numbers of patients who
are distributed over large geographic areas. New technologies may play an important role in
ensuring that high-quality data can be quickly and reliably collected under these challenging
field conditions. Ideally, organizations or individuals that need to record large amounts of data in
dispersed locations would be able to electronically capture these data at the point of collection. In
clinical and research settings within developed countries, personal digital assistants (PDAs) have
shown some promise as a new technology which can increase the quality and efficiency of data
collection, though performance has varied between studies'1 49 150 152-156 158 159 161 172-175. This
heterogeneity may suggest that the design and implementation of the PDA intervention play a
key role in a system's success. In resource-poor settings, initial experiences have demonstrated
several situations in which PDAs 75 111 112 160 169-171 176-179 and cellular phones' 80 181 are of benefit.
However, to date, we have found no quantitative studies of the impact of mobile technologies on
the time to collect and process data, the frequency of discrepancies, or the number of person-
hours required for data collection.
As described in the previous chapter, we worked with Socios En Salud, an organization that
monitors multi-drug resistant tuberculosis (MDR-TB) patients in Peru, to implement a PDA-
based system and study the impact of this system on data collection. The major disadvantages of
this paper-based method are the delays in processing and entering laboratory results, data quality
issues stemming from multiple opportunities for transcription errors, and the heavy work load
involved in the process. A preliminary study found that the mean time from the test result date to
entry in the PIH-EMR was 55.3 days. A routine quality control examination found error rates as
high as 10.1%, and the bacteriology team was consistently backlogged because of the increasing
number of patients on treatment.
The study described here evaluated a PDA-based system which we implemented in an attempt to
alleviate these problems 25. The specific aims of this study were:
1. To compare the processing time using the electronic system to the paper-based system;
2. To compare the frequency of errors entered with and without the electronic system;
3. To assess the system's usability and its acceptability by users.
4.2 Methods
4.2.1 Study Design and Parameters
After collecting baseline data for 19 months from four of five health districts in Lima, Peru, we
randomly assigned two to the intervention while two were maintained as controls. During the
intervention period, we collected data on the same endpoints in both control and intervention
arms (Figure 4.1). This allowed us to perform a prospective comparison between the intervention
and the control arms (between-districts comparison) as well as a historical comparison
comparing each arm to itself before the intervention began (within-districts comparison). This
complementary design using two comparison groups allowed us to minimize the risk that the
changes measured were due to secular changes in the regions studied or to baseline differences
between the arms. Since the potential sources of bias should be independent, observing similar
effects in both comparisons should offer reassurance that our conclusions are valid.
Control Districts(n=2) I Paper-based System
Within-Districts Comparison Between-Districts
___ 
Comparison
Intervention Dists
nterventionDistris Paper-based System PDA-based System
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Figure 4.1 Cluster randomized controlled trial schema with within-districts (before and after) and between-districts
comparisons
4.2.2 Processing Time
We defined the processing time as the number of days from the date of the bacteriology result to
its entry into the PIH-EMR (Figure 4.2). The activities included within the processing time were
visiting the health establishment to collect the information, processing and verifying that
information at the office, and entry into the PIH-EMR for clinical and administrative use. A part
of the processing time was the collection time, from the date of the bacteriology result to its
collection by the team. The collection time was not affected by the intervention, but was
included in the processing time because it could not be separated in the retrospective data used
for the within-districts comparison. We analyzed the between-districts data and found that there
was no statistically significant difference between collection times in the intervention and the
control districts.
Processing Time
Bacteriology Collection Verification EMR entry
result date date date date
Figure 4.2 Definition of processing time
4.2.3 Collection Errors
We defined a collection error as an occurrence when information entered into the PIH-EMR did
not match the original laboratory notebook (gold standard). We recorded all variables collected
for cultures and smear microscopies. These included result date, identification number, result,
and if the result was assigned to the wrong patient (misidentification errors).
We expected a decrease in all types of errors since data had to be entered only once in the PDA-
based system compared to three times in the paper-based system. The additional forms in the
paper-based system were necessary to organize the information for both clinical and
administrative purposes. In the PDA-based system, these forms were placed online and generated
automatically. Further, the PDA-based system had a full patient list from which the user could
select a patient name. We believed that having this utility would reduce the number of
misidentification errors since the users would not have to remember all active patients when they
searched for results.
4.2.4 Usability and Acceptability of System
A survey that had been previously used in Peru80, was administered to measure the usability and
acceptability of the system (Appendix A). The survey was modified for our intervention,
validated with other employees from our organization Partners In Health and Socios en Salud,
and given to the bacteriology team. The responses were short answers or given on a five-point
Likert scale anchored by l=very negative, 5=very positive. The survey examined four themes:
the amount of time each user spent collecting information, the amount of training required for
each of the two systems, the effect of the PDA on the user's interaction with health care
personnel, and the quantity of technical problems.
4.2.5 Data Abstraction
For the between-districts comparison, we collected all culture and their respective smear
microscopy results for the six months after the full implementation of the PDA-based system
(result dates between March 24 and September 24, 2006).
For the within-districts before-and-after comparison, we collected all culture and smear
microscopy results entered into the PIH-EMR during the routine operation of the bacteriology
team before the intervention from January 1, 2004 to July 31, 2005. Two exclusion criteria were
used and the quantities and percentage of results eliminated are shown in parenthesis: (1) The
PIH-EMR entry date was before the result date (2 smears 0.01%, 18 cultures 0.2%); (2) The
processing time was greater than 1 year. This eliminated results collected during retrospective
searches and not during routine collection (100 smears 0.8%, 223 cultures 2.1%).
We compared the data entered in the PIH-EMR with the original laboratory register by visiting
each clinical site. Twenty five percent of results were reviewed a second time and we found
excellent agreement (99%) with the original data. All questions about errors were resolved by a
consensus between the bacteriology team and me.
4.2.6 Statistical Analysis
To compare processing times, we used a random effects model.182 183 There were two fixed
effects: intervention and period (pre- and post-implementation) in the model. District was used
as a random effect since the individual observations within the district might be correlated. To
test the fit of the random effects model, we looked at the residual and QQ plot (Figure 4.3). For
the residual plots in both culture and smears, the equal distribution of the residuals above and
below zero shows that there are no data points that will be unusually influence the outcome of
the test. For the Q-Q plots for cultures and smears, the distribution approximates a straight line.
Only the far edges deviate and therefore we accepted the null hypothesis that the data were
normally distributed after log transformation.
SfM. i cm
Figure 4.3 Diagnostic plots for random effects model used to compare processing times
The response variable, processing time, was log transformed as it had a right-skewed distribution
(Figure 4.4). The intervention effect was tested with the period as a block in the model. The
intracluster correlation coefficients (ICCs) calculated for culture and smear microscopies were
0.025 and 0.102, respectively. For the collection errors, we fit a Generalized Linear Mixed
Model (GLMM) 18 4 185 to test for the effect of the intervention since response variable 'collection
error' and 'misidentification error' were binary (1 for presence of error, 0 otherwise). In the
second model, ICC's were 0.049 and 0.064.
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Figure 4.4 Log transformation of processing time for both culture and smear microscopies
As the collection processes differed for cultures and smear microscopies, the analysis of
processing time was done separately. Smear microscopy was usually performed at a local health
centre and the result communicated to a regional laboratory where the culture was performed.
The smear microscopy data were collected from both locations and cross-checked before being
entered into the PIH-EMR. Culture results were always collected from the regional laboratory.
For the collection errors, both the process of extracting results from clinical settings and the
variables collected were similar, so culture and smear microscopy results were combined.
Additional data fields were implemented in the PDA system at the request of the users; however,
these fields were not taken into account for the collection errors.
4.3 Results
Characteristics of the intervention and control districts are summarized in Table 4.1. The number
of monthly results collected by the bacteriology team since 2004 (pre-intervention) has increased
for both sets of districts. The control districts had more health centres from which data were
collected (58 vs. 35) and more monthly results collected (2255 vs. 785) compared with the
intervention districts. The number of years working in the bacteriology team (mean 4.5 vs. 4.9
years) and years of internet experience (mean 4.3 vs. 4.6 years) were similar before and after the
PDA-based system was implemented, primarily because three team members participated in all
periods of the study.
Table 4.1 Descriptive statistics of samples for study
Before After
Intervention Control Intervention Control
Districts Districts Districts Districts
Smear microscopies for processing time 5846 6376 2791 3435
Cultures for processing time 4876 5954 2890 3263
Smears and cultures for collection errors 677 N/A 1112 970
Health centres from which data were collected 35 58 35 58
Mean monthly smear and culture results collected 315 460 785 2255
Mean years as team member 4.5 4.5 4.9 4.9
Mean years using Internet 4.3 4.3 4.6 4.6
Culture Collection Time (days)
Mean 43.2 43.2 9.9 35.1
Standard Deviation 39.8 40.3 10.1 45.6
Median 30.5 30.7 7.7 22.5
IQR 35.2 41.5 7.7 26.1
Smear Collection Time (days)
Mean 32.6 42.5
Standard Deviation 34.0 43.2
Median 21.5 27.7
IQR 30.1 40.7
Bacteriology team member characteristics are identical within the before and after
the same and they rotated between the intervention and control districts.
IQR = interquartile range
15.0
12.2
11.6
11.3
comparisons because
34.3
38.2
24.6
19.8
users were
4.3.1 Processing Times
The effect of the intervention on processing time was highly significant in both culture and
smear (p<0.001, p<0.001). In the random effects model for cultures, the period effect was also
significant (p<0.001) and the ICC was 0.025 implying relatively small variability compared to
the random error. For the smears the period was also significant (p<0.001) but the ICC was
slightly bigger, 0.102.
Median culture processing time for the intervention districts was 65.8% less (7.7 vs. 22.5 days)
in the between-districts comparison and 74.8% less (7.7 vs. 30.5 days) in the within-districts
comparison (Figure 4.5a). For smears, the PDA-based system was associated with a 52.8% (11.6
vs. 24.6 days) and 45.8% (11.6 vs. 21.5 days) reduction in delay measured in the between-
districts and within-district studies, respectively (Figure 4.5b). We also found that the control
districts had a decrease in processing times for both cultures (22.5 vs. 30.8 days) and smears
(24.6 vs. 27.7 days) after the PDA-based system was implemented in the intervention districts.
Furthermore, the timing of data entry with the PDA-based system was more predictable than the
paper-based system. The interquartile range (IQR) for culture processing time in the intervention
districts (7.7 days) was smaller than that for the between-districts (26.1 days) and the within-
districts (35.2 days) comparisons. This effect was also observed for the smear microscopy results
(11.3 vs. 19.8 and 30.1 days, respectively).
Finally, this system was able to almost eliminate outliers defined as processing time of over 90
days (Figure 4.5c and d). At baseline, 9.2% and 8.2% of cultures had a processing time of at least
this long for the intervention and control districts, respectively. This decreased to 0.1% in the
intervention district post-implementation compared to 5.4% in the control district post-
implementation. The same phenomenon was observed for smear results where the pre-
implementation values were 6.0% and 9.1% for the intervention and control districts,
respectively, and they decreased to 0.1% and 4.8% post-implementation.
CUTIJURE
-r 3
I S
I ,
:I j_ *
* I I
* I I j
* I
a. I 10
a.! i I
* 0
9 0
r
t
F _A6 1 1 I 1 Con duWaUmn cmstroi fritvmlon
D.f Disrics -bct
Bre Aftr
I'
V o qN
(b)I
Abw
Figure 4.5 Box plot for processing time of (a) cultures and (b) smears in log scale (left y-axis) and days (right y-
axis). These show that for both culture and smear results there was a statistically significant decrease (p<0.001) in
the processing time with the PDA-based system (intervention districts after) compared to the same districts before
the implementation (intervention districts before) and districts with the paper-based system (control districts after).
The Kaplan Meier survival curves for the initial 100 days for (c) culture and (d) smear microscopy show that the
PDA-based system was able to drastically decrease the number of outlying results with a processing time of over 90
days.
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4.3.2 Collection Errors
After fitting GLMM's, we found that the intervention had a significant effect on the total
frequency of collection errors (p=0.005); the fraction by which errors were reduced was 57.1%
for the between-districts comparison and 39.1% for the within-districts comparison. The
proportion of results with errors in the intervention districts was 2.6% (29 of 1112 results)
compared to 6.1% (59 of 970 results) and 4.3% (29 of 677 samples) in the control districts and
the baseline intervention districts, respectively (Figure 4.6).
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Figure 4.6 Proportion of total and misidentification errors comparing the intervention districts after theimplementation to the historical control group (intervention districts before) and the prospective control group(control districts before).
Despite finding 80-85% fewer results with misidentification errors in intervention districts for
both the between-districts and within-districts comparisons, we could not conclude that the
intervention significantly lowered the frequency of this serious type of error (p=0.074). This is
largely attributable to small numbers of these types of errors overall; intervention districts had an
error rate of 0.09% (1 in 1112 samples) compared to 0.62% (6 in 970 samples) in the control
districts and 0.44% (3 in 677 samples) in the baseline data for the intervention districts. Unlike
processing time, the period effect was not found to be significant for either type of error
(p=0.554, p=0.064). The ICCs were small for both collection errors (0.049) and for
misidentification errors (0.064).
4.3.3 Usability and Acceptability of System
The user feedback about the electronic system was positive, with all four users preferring the
PDA-based over the paper-based system. After less than five days of practice, each of the users
became comfortable with using the PDA to enter information. The users noted the ability to
quickly verify and transfer results electronically instead of working with large amounts of paper
and to access an updated patient list automatically uploaded to the PDA instead of having to
manually create it every week as favourite features of the electronic system. The users asked to
conclude the study early so that the system could be expanded to all health districts in Lima as
soon as possible.
All users found it easier to learn to use (mean 4.0 out of 5) than the paper based system (mean
3.5 out of 5), to collect results with the PDA (4.5 vs. 3.5), and to process results (4.75 vs. 3.0).
All users said that the intervention affected their relationship with the local health centre
personnel in a positive or very positive way. Two of the users expressed that it improved their
relationship because it seemed more professional and they could explain its use.
4.4 Discussion
Many organizations must collect information from a population which is distributed over a large
area. In a previous publication, we reported on the design and implementation of a PDA-based
system to collect TB bacteriological data from many institutions 25. In this full evaluation, we
found that the use of this system was associated with a substantial reduction of the delays from
collection to entry of laboratory results, a decreased frequency of errors, and a reduced workload
for those involved in data collection and processing.
This system was able to reduce the median processing time by 46-74% depending on the type of
result and comparison. Also, the intervention almost eliminated large delays of over three
months from between 6-9% to 0.1%. The intervention districts had 39% and 57% fewer errors
than the baseline intervention and control districts, respectively. We believe this improvement
resulted from eliminating manual data entry and providing electronic verification tools. Finally,
the intervention lowered the person-hours spent processing and verifying data and was well-liked
by users. One user wrote "With the paper system our work was always late. With the PDA
system our work is up to date." Providing more timely and accurate bacteriology data to
clinicians should allow them to monitor their patients better and reduce the amount of time that
patients are infectious. This is the first quantitative evaluation showing that a user-friendly PDA-
based system to collect data in resource-poor settings can significantly reduce processing time,
decrease the frequency of collection errors, and lower the effort required for processing.
We also found that the control districts had a decrease in the mean delay of 27% and 11% for
cultures and smears, respectively, compared to the pre-intervention delay. In reviewing the
results with the team, they asserted that the main reason for this decrease was that they had more
time to work in the control districts because their work load in the intervention districts was
reduced.
Another possible measure of the success of this system is its continued use and expansion. After
the study period, the PDA-based system was transferred to our Peruvian partners. This process
consisted of training their technical team and providing monthly technical advice via phone. At
the request of the users, they have expanded the system to the control districts, one additional
district in Lima and five provinces of Peru. Additionally, four new users have been added with
the leaders of the bacteriology team preparing and performing the training. Finally, at the request
of the clinical staff, the same system is currently being extended to incorporate the collection of
patient weight and height data. All activities and costs for these additional activities are
described in Chapter 5.
4.4.1 Limitations of study
Though this study is small, with four users in four health districts, the use of dual comparison
groups (between-districts and within-districts before-and-after) helped us to minimize potential
biases due to secular trends and baseline between district differences. Further, we took other
steps to reduce sources of bias by rotating the users of the system and ensuring that no other
changes in collection were made during the study. Finally, this was a formative, rather than
summative, evaluation since the developers were involved, although the expansion and
continued maintenance of the system by local staff independent of the original developer shows
its sustainability.
4.5 Conclusion
This study shows that a well designed PDA-based system can provide large improvements in
community data collection for clinical and administrative purposes, even in resource-poor
settings. These systems can provide higher quality data with fewer communication delays and
person-hours required, though the effort, time, and attention to detail required to create these
systems must be taken into account. These benefits might also be seen in the use of cellular
phones, especially smart phones. However, their user interface and connectivity with a larger
record system must be studied further. Organizations working at the community level or
requiring data from institutions spread over a large area should consider the advantages of using
mobile data collection systems.
5 Cost Analysis of PDA-based System
This chapter describes a cost analysis and time motion study performed on the PDA-based
system. Here we evaluated the system's effect on users' workloads and their perception of the
system's effect. We also performed a cost-analysis of implementing and expansion of this
system. Finally we provide a framework and case-study of how to implement PDA-based
systems in resource-poor settings.
5.1 Introduction
Many clinical and research organizations must collect data from locations distributed over a
large area to monitor patients, conduct surveys, or perform research. Although there is still some
debate in developed countries, many studies have shown that personal digital assistants (PDAs)
can increase communication and reduce discrepancies for these purposes 49 150 152-156 158 159 161 172-
175. In resource-poor settings, implementations of PDA-based systems for data collection are
increasing 75 111 112 160 169-171 176-179 186 187, however, to date, we have not found any quantitative
studies of the development and implementation costs and potential savings associated with using
these technologies for data collection. There are many important unanswered questions for
institutions or projects considering using these technologies. Among them are: what are the
initial and recurring costs of using these types of systems? How long will it take to implement?
What are the processes required to create and implement a functional system? Will the
investment in information technology pay for itself?
5.2 Methods
5.2.1 Study Design and Data Collection
To assess the intervention's effect on the team's work, we performed a time-motion study,
described below, during a prospective controlled trial, described in Section 4.1, where four of
five health districts in Lima, Peru were selected by chance to the PDA intervention or the current
paper system. Since team members spend little time on any individual task, we chose a type of
time-motion study formerly used at the Regenstrief Institute for Health Care 88 .
The time-motion study was performed six months after full implementation of the PDA-based
system (March 24-Sept. 24, 2006) and consisted of a single observer following the team
members during routine data collection. The assistant assigned all tasks to one of the pre-
established set of categories (Table 5.1). Each task was visually identified when it began, without
verbal explanation by the team member. It was timed using a stop watch and results rounded to
the nearest half minute. The observer then recorded the task, start, and end times. Since there was
continual observation of users there were no missing data. There are fewer categories for the
PDA-based system because many paper processes were automated or eliminated. For example,
sheets with patient names were eliminated since this information was in the PDA. Also, manual
entry of results into the PIH-EMR was replaced with an automated transfer feature. If multiple
identical tasks were performed consecutively, the time for the group was recorded. All materials
used by the BC team were also logged.
To calculate the average time per result for collection, the total number of minutes for all
processes was divided by the total number of results collected. In order to calculate average
processing time, the total number of minutes for all processes was divided by the total number of
results entered into the PIH-EMR. The total number of results collected or entered were used for
the denominator since all of the other processes were performed on a sub-group of there results.
Thus, this average time per result for collection or processing includes all processes required on
any sample.
Cost data on the development and implementation of the intervention were collected from the
beginning of the project, one year before the study. Data on the technology transfer and
expansion were collected for one year after the study. All costs are in 2006 US$.
Table 5.1 Time-Motion study results for collection and processing tasks showing the number of samples, mean
minutes per sample, the change caused by the PDA-based system, and corresponding p-value for each task.
Paper System PDA-based System
mean minutes mean minutes Estimate of change
Task Samples per sample Samples per sample (difference) p-value
Recording smear result 709 1.08 594 1.51 0.43 0.07
Verifying smear result 12 3.67 128 2.26 -1.41 0.78
Recording new culture test 319 0.53 483 0.78 0.26 0.89
Recording culture result 552 0.38 639 0.42 0.05 0.90
Verifying culture result 18 2.50 3 4.33 1.83
Waiting (total minutes) 301 138 -163
Total smear collection time 709 1.36 594 2.11 0.75 0.12
Total culture collection time 552 1.04 639 1.15 0.11 0.31
Enter smear to PIH-EMR 970 0.77 1277 0.06 -0.71 < 0.001
Process smear 193 1.06 230 1.45 0.39 0.12
Copy smear 887 3.03
Enter culture to PIH-EMR 1134 0.77 1442 0.06 -0.71 < 0.001
Process culture 198 1.04 353 1.36 0.32 0.02
Copy culture 575 2.50
PDA synchronization 29 7.90
Create new patient sheet 44 6.59
Update patient list 458 0.71
Prepare materials 364 1.01
Photocopy collection sheet 165 0.67
Total smear processing time 970 4.09 1277 0.41 -3.68 <0.001
Total culture processing time 1134 3.68 1442 0.47 -3.21 <0.001
Total smear time 5.45 2.52 -2.93 0.01
Total culture time 4.72 1.62 -3.10 0.01
To calculate the average time per result for collection, the total number of minutes for all processes was divided by
the total number of results collected. In order to calculate average processing time, the total number of minutes for
all processes was divided by the total number of results entered into the PIH-EMR. The total number of results
collected or entered were used for the denominator since all of the other processes were performed on a sub-group of
results. Thus, this average time per result for collection or processing includes all processes required on any sample.
5.2.2 Statistical Analysis
We used a t-test for two independent samples to analyze the differences in the means of the time-
motion study with the Satterthwaite's approximation for the degrees of freedom because of the
unequal variances between the groups. Two-sided p values < 0.05 were considered statistically
significant.
5.2.3 Costing
We collected the tasks and costs of developing, implementing and transferring the PDA-based
system to the local organization (Table 5.2). Since system requirements were developed
iteratively, development and implementation occurred simultaneously. However, we have
separated them for clarity.
Personnel costs were approximated from standard salaries at non-profit organization in each
respective country. A US-based developer's hourly rate is $30 ($60,000 annually) and an
advanced US-based programmer's $35 ($70,000 annually). The average annual salary of a
Peruvian data collector, information technology (IT) technician, and developer are $3,000
(average Peruvian salary is $2620189), $12,000, and $18,000, respectively.
The paper system had been in use at the local organization for over 7 years, so it was not possible
to measure its development costs. For recurring costs, we collected data on the functioning of the
BC team. This included the time-motion study and recording all materials used.
Table 5.2 Processes and costs of developing and implementing PDA-based system, 2006 US$
Costs
Paper PDA-based
Process Name Description (US$) system (US$)
Workflow Assessment
Site Visits 1 two-week Peru trip by developer: flight, hotel, food $1,500
Learning workflow 2 week full-time developer $2,400
Meetings with team members 2 two-hour meetings, developer with 4 person BC team $152
Development
Learning PDA software 2 weeks half-time developer $1,200
Learning software for PIH-EMR 2 weeks full-time developer $2,400
Training on PIH-EMR by advanced
programmer 5 days half-time advanced programmer $700
Creation of PDA forms, decision support
& transfer modules in PIH-EMR 10 weeks half-time developer $6,000
Consults to advanced programmer 4 days half-time advanced programmer $560
Writing of user manual 2 full-time days developer, 1 full-time day BC team member $496
Deployment
Site Visits 2 two-week Peru trips by developer: flight, hotel, food $3,000
3 days full-time developer, 2 days full-time Peruvian
Installation developer $912
Trainings 2 two-hour meetings, developer with 4 person BC team $152
4 weeks half-time, 8 weeks quarter-time developer, 12
Troubleshooting weeks 0.1-time BC team member $4,875
Technology Transfer
Writing technical manual 1 full-time day developer $240
1 two-hour meeting, developer with 2 Peruvian developers,
Training technical personnel 10 one-hour Skype conversations $480
Materials
3 work & 1 backup PDAs, accessories, Pendragon Forms
PDAs, accessories, software license, Oracle software $1,025
Office supplies Folders, Filing cabinets, paper $279
TOTAL $279 $26,092
5.2.4 User's perception
A survey, used previously in Peru 190, was employed to assess users' time spent on each sample
and the technical problems experienced. The survey was modified, validated with other
employees, and given to the team after study completion (Appendix A). Responses were on a
five-point Likert scale (1=very negative, 2=negative, 3=neither negative nor positive, 4=positive,
5=very positive) or short, numeric answers. For Likert scale responses, scores were averaged
across all users. The short, numeric answers, such as number of technical problems per month,
were also averaged across all users.
5.3 Results
Baseline characteristics are summarized in Table 5.3. The control districts had more health
centers (58 vs. 35) and more monthly results collected (2,255 vs. 785). The BC team's work
experience (mean 4.9 years) and years of internet experience (mean 4.6 years) are identical
between intervention and control districts because all team members rotated between districts.
Table 5.3 Sample sizes for smear microscopies and cultures collected during study, number of health centers, mean
monthly results, and average experience of users for control districts (current paper system) and intervention
districts (PDA-based system).
Intervention Districts Control Districts
Collected smear microscopies 594 709
Collected cultures 639 552
Processed smear microscopies 1277 970
Processed cultures 1442 1134
Health centers from which data were collected 35 58
Mean monthly smear and culture results collected 785 2255
Years as BC team member
Mean 4.9 4.9
Minimum 1.5 1.5
Maximum 7 7
Years using Internet
Mean 4.6 4.6
Minimum 1.5 1.5
Maximum 8 8
BC team member characteristics are identical because all users rotated between the intervention and control districts
before and after the implementation of the PDA-based system.
5.3.1 Time-Motion Study
Overall, time spent collecting and processing results decreased by 54% (5.45 to 2.52 minutes) for
smear microscopies and by 66% (4.72 to 1.62 minutes) for cultures (Table 5.1). If the PDA-
based system were expanded to all sites, the time saved would be 221 person-hours per month.
To further analyze this, processes were divided into either collection or processing categories.
In the collection categories, the PDA-based system had a larger average collection time for both
smear microscopies (1.36 to 2.11 minutes) and cultures (1.04 to 1.15) than the paper system
(Table 5.1). This was partly due to additional collection fields implemented in the PDA. For
smears, this increase was largely due to more verified smears in the intervention than control
districts (128 to 12 samples) though the average time was less for the PDA (2.26 to 3.67
minutes). This difference was due to additional regulations in the intervention districts adopted
by the control districts after the study.
In the processing categories, the PDA-based system required 90% less time for smear
microscopies (4.09 to 0.41 minutes) and 87% for cultures (3.68 to 0.47 minutes) than the paper
system. The major contributor was the elimination of office processes such as creating new
patient sheets and of duplicate entry at the clinical site and then into the PIH-EMR.
5.3.2 Costs
The total cost of implementing, developing and transferring the PDA-based system was $26,092
(Table 5.2). These costs included a US-based developer travelling to Peru to learn the team's
workflow and deploy the system. It also included software development (12 weeks), testing and
troubleshooting (12 weeks), and writing instructions (2 days). There were frequent emails
between the developer and users during these periods, which decreased considerably after full
implementation. Materials for the system totaled $1,025 and included 3 PDAs with accessories
and Pendragon Forms licenses (Table 5.2). Training for the use of this system consisted of
writing a user guide and two four-hour training sessions. Finally, the US developer trained a
Peruvian IT technician and programmer to maintain and update the system.
This Peruvian technical team expanded the PDA-based system to the three remaining health
districts in Lima and to nine health district in other provinces in Peru. The total time and cost for
this expansion was three months and $1,125 (Table 5.4). It took this long because the technicians
needed to learn to both troubleshoot and expand the current forms. Also, at the request of the
clinical team, the Peruvian technical team created an additional data collection form for patient
weights. This took five months and cost $4,107. The initial creation took two months, however
they encountered a bug in Microsoft Access@ which took three months to solve. We therefore
believe this example over-estimates the cost of implementing additional collection forms.
Additionally, six new users were trained by the leaders of the original BC team.
The paper system costs consist of fixed costs such as filing cabinets and folders ($279) and
recurring monthly costs of photocopies and printouts ($32). Development costs could not be
measured since it had been implemented for over 7 years.
Table 5.4 Costs of expanding PDA-based system to 9 additional districts and implementing additional data
collection form by Peruvian personnel, 2006 US$
Process
Development
Learning to manage system
Expanding forms for new districts
Deployment
Installation
Trainings
Troubleshooting
Materials
PDAs, accessories, software
TOTAL
Development
Creating requirements for additional
form
Learning and creating additional form
Solving technical problem with lack of
decimal point
Deployment
Installation
Trainings
Materials
PDA, Computer
TOTAL
Description
10% time information technology (IT) technician 3 months
5% time IT technician 3 months
2 hours IT technician
3 trainings led by original data collection team for 6
community health workers, 3 hours each
5% time IT technician and data collection team member 3
months, 8 hours Peruvian Programmer
2 palms (1 additional, 1 replacement), accessories, 2
additional Pendragon Forms licenses
2 leaders of data collection team 1 day
40% time IT technician 2 months
30% time IT technician and Peruvian programmer 3
months
2 hours IT technician
1 hour training by IT technician, 3 hours training by
original data collection team
1 PDA for performing testing by IT technician, 1 PC to act
as additional synchronization station
5.3.3 Break-even Point
The break-even point, at which savings on personnel and materials costs equal intervention costs,
for the development and implementation of the system was 66.3 months or 5.5 years (Table 5.5).
More importantly, the break-even points to expand from two to eleven districts and create
additional forms were 2.9 and 10.4 months, respectively (Table 5.5). These calculations assume
identical monthly savings.
Cost(US$)
$288
$144
$12
$113
$182
$387
$1,125
$25
$768
$2,160
$12
$22
$1,120
$4,107
Table 5.5 Sensitivity analysis for break-even point of implementing and expanding PDA-based system. All costs
are in 2006 US$.
Item Quantity/Cost
Average monthly tests entered by BC team 4,406
Average time saved per test (minutes/result) 3.01
Monthly work hours saved (hours) 221.01
Average monthly salary of BC team (US$) $264.03
Monthly savings from increased efficiency (US$) $364.71
Monthly savings from materials (US$) $29.00
Total monthly savings (US$) $393.71
Months to break-even Implementation
Materials only 2.6
Total Cost 66.3
Months to break-even Expansion
Expansion of Current System to 9 districts 2.9
Implementing Additional Collection Forms 10.4
5.3.4 User's perception
Overall user satisfaction was higher for the PDA (mean 5 out of 5) than for the paper (mean 3.5
out of 5). Users responded that the intervention reduced mean time per result from 6.75 to less
than 2 minutes. Over the six month implementation period users experienced, on average, 1.13
technical problems per month which they themselves could fix in the field (2 users) or back at
the office (2 users).
There were also role changes because each SES team member was able to collect and enter their
own data without having to rely on other team members or additional data entry personnel. One
user said "Now it's faster because we verify and enter the data ourselves."
5.4 Discussion
The previous chapter showed that a PDA-based system to collect bacteriological data from many
institutions without internet could reduce processing delays and errors 25. In this chapter, we
showed, in a time-motion study, that it reduced the person-hours required to process samples by
over 50% compared to the paper system and that users felt this reduction was 70%. We also
provided a framework to develop, implement, and transfer such a system to a local organization
in a resource-poor setting. This framework identifies the personnel, processes, and costs required
to either create a new system or to expand the one described in this thesis.
In the time-motion study, the increase in collection time by the PDA-based system for smears
occurred mostly because of two reasons. The first is a baseline difference due to a legal policy in
the intervention districts requiring communication of smear results from health centers to
regional laboratories. This meant that the SES team had to verify the communicated results.
During the time of this study only the intervention districts had this policy, though it is now
active in all districts. The second reason was that 3 or 4 additional fields were implemented in
the PDA for culture and smear results, respectively, at the request of the SES team.
The implementation times and processes described here should be broadly generalizable to
organizations having at least one individual with basic IT experience. For the costs of the project,
however, local wages should be substituted to arrive at the actual cost. The majority of the PDA-
based system's cost was the US-based developer's salary. It for 86% ($22,439) of the total
project cost of $26,092. A more cost-effective model would develop the system locally rather
than in the US. Both system expansions described here were performed by local developers. The
number of work-hours were 20% less than original development (539 vs. 670 hours), but the cost
was 80% less ($5,232 vs. $26,092).
Three essential parts of the development framework that should be emphasized are: user
appropriation of the system, iterative development cycles, and a prolonged technology transfer
period. First, having users appropriate the system is crucial to its ability to foster improvement
and its sustainability. A thorough workflow assessment is essential to this process 191 because it
involves future users at the beginning of the development process. Also important for user
appropriation is their constant input when troubleshooting the system. Conversations with users
of the PDA-based system confirmed their sense of ownership because they participated in the
entire development and implementation processes. Second, iterative cycles between development
and deployment are required to have all functionality working appropriately; however if a
thorough workflow assessment is performed at the beginning, fewer cycles (and less
development time) can be expected. For most systems, if there is a single design period, it will
not be able to meet all user needs and have a higher chance of failure. Finally, transferring
technology for local administration of a system consists of more than a well-written user manual
and a few meetings conducted within a short time frame. There must be planning from the
beginning of the project and continued conversations over time (probably months, if not years)
when unforeseen issues arise.
There were limitations to this study. A few costs could not be accounted for, such as the external
data entry personnel required to enter backlogged data or the time required to create reports. All
of these unmeasured costs were related to the paper system and therefore would have made the
PDA-based system more affordable in comparison. Also, the PDA-based system was partly
created in the PIH-EMR, an already-implemented medical record system. However, a simpler
system could be created using MS Access®. Finally, this was a formative, rather than summative
evaluation since the developers were involved, though the expansion and maintenance by local
staff shows the system's sustainability.
More organizations should be able to use this or similar systems since the technical barriers and
costs of local development of PDA-based data collection systems are currently being lowered.
For example, Epihandy (www.epihandy.org), a PDA form creation tool, has recently been
programmed to connect to the medical record system OpenMRS (www.openMRS.org). A similar
effort is underway with EpiSurveyor (www.datadyne.org), another PDA form creation tool. All
are open source software that are available free on the Internet and offer a potentially low cost
and sustainable system, though more development may be required to match the flexibility of
Pendragon Forms®.
5.5 Conclusions
This chapter describes the processes and costs of implementing a PDA-based system to collect
data and its ability to significantly decrease collection and reporting times. It also shows the cost
savings resulting from expanding the existing system and shows the time and resources required
for this expansion. These results should guide organizations that need to collect data from many
locations and provide an estimate of the time, costs, and personnel requirements for the
implementation of an electronic system. With the methodology described, local developers, and
free, open source software becoming more available, many organizations could reap the benefits
of this technology.
6 Design and Implementation of e-Chasqui, a Web-based
Tuberculosis Laboratory Information System
This chapter describes the design and implementation of a web-based TB laboratory information
system to communicate data between a national laboratory, two regional laboratories, and 12
health centers (HC) in Lima, Peru. This system was designed to support a national TB laboratory
network connecting all participating institutions. We then describe the expansion of the system at
the request of the public administration. Finally, we examine broader issues of implementing
these types of systems in resource-poor settings including costs and sustainability.
6.1 Background on organization
SES, Harvard Medical School, and the US Centers for Diseases Control and Prevention (CDC),
in collaboration with the Peruvian Ministry of Health (MINSA), are performing a study
"Operational Assessment of Rapid Diagnostic Methods for MDR-TB in Lima, Peru" to
decentralize drug susceptibility tests (DST) and increase regional laboratory capacity. This
implementation of decentralized, rapid DST is underway as part of nationwide efforts to scale up
services for detection and treatment of MDR-TB and extensively drug resistant TB (XDR-
TB) 192 . Whereas initially only the Peruvian National Reference Laboratory (NRL) performed
DST, the capacity of the regional laboratories has expanded to include rapid and conventional
first-line DSTs. The typical flow of a suspected TB patient's sputum sample from the initial
treatment site through the laboratory network is depicted in Figure 6.1. Each test result is
communicated serially, and in each step, there are delays and the potential to lose the result.
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Figure 6.1 Tuberculosis laboratory structure/workflow in Lima and locations of e-Chasqui implementation
A study of turn-around-times (TATs) for cultures and DSTs within the Peruvian public health
system suggests that patients could still experience risky delays despite availability of
decentralized, rapid DST unless programmatic aspects are also addressed15. In addition to
reducing communication delays, minimizing lost and erroneous results is essential for reducing
morbidity in these high-risk patients. To improve these aspects, we developed and implemented
the laboratory information system described herein.
6.2 Methods
6.2.1 Needs Assessment
The first step in creating the laboratory information system was to conduct a needs assessment of
the major stakeholders: the personnel in the HCs, regional, and national laboratories. After
working with the director, laboratory technician and data entry staff in the participating
laboratories and the TB clinician, nurse and local laboratory technician in several key HCs, a list
of information requirements was created, shown in Table 6.1. While most requirements were
identified during this initial period, others emerged during the implementation process.
Table 6.1 Needs assessment of health centers and laboratories
Health Centers
All information displayed to mirror paper forms
Find patient by name despite constant misspellings
Fast access despite low bandwidth
Easily access patient's individual result and history of all results
For a sample view all tests performed and date when sample was taken
View all recent results by HC
Track all tests pending by HC
Access information on samples collected in other institutions (e.g. while
hospitalized, prior to transfer to their HC)
Email notification of new test results
Print out a test result in the official MINSA format
Display trend in DST requests by HC
Show MDR-TB patients not appropriate treatment
Current patients failing treatment
Access latest information on evidence-based TB treatment
Laboratories
Integrate into laboratory workflow with minimal disturbance or increased work
Search for sample by ID number
Individual results printed in current paper form
Aggregate reporting for all tests entered
Ability to view all culture and DST results reported within an arbitrary time period
Improve quality control of test results
Ability to modify or "grow" system with continual requirements
Compatibility with existing computerized information systems
6.2.2 Integration into Laboratory Workflow
The laboratory information system needed to be integrated within the workflow of the busy
regional and central laboratories. We performed a thorough workflow analysis of each
laboratory's systems of information, each staff's responsibilities, quality control, and tests
performed, and designed the system to follow the current workflow of intake, processing, and
reporting. However, the integration of the information system still required workflow
adjustments to incorporate data entry, digital verification, and printing of results from the system.
This was done through iterative discussions with the laboratory directors followed by an hour-
long training session for all laboratory personnel. These changes in workflow, however, did not
result in increased time demands; instead the revised system resulted in greater efficiency for
most laboratory personnel, since the database (with reliable back-up) obviated the need to
photocopy and maintain physical copies of all results at the laboratory.
Finally, the laboratory information system had to integrate with current laboratory reporting
systems being used. During the implementation of e-Chasqui the NRL moved from using the
PHLIS laboratory reporting system, 130 to an in-house developed laboratory management system.
To communicate data between these systems, a tool was created to manually export all results;
we are currently defining other inter-system communication methods.
6.2.3 System Design
The electronic laboratory information system, called e-Chasqui 2 (Figure 6.2), supports the
decentralized entry and viewing of bacteriological tests (smear microscopy, cultures, species
identification, and DSTs). In addition, it includes applications to assess quality control, generate
aggregate reports, notify health centers of new results or contaminated samples, and track both
enrolled patients and the status of pending laboratory tests. e-Chasqui extends the web-based TB
electronic medical record system, PIH-EMR, that has been in use in Peru since 2001168 193. To
protect patient's confidentiality, e-Chasqui incorporates extensive encryption and web security
features for medical records of the PIH-EMR 68. Furthermore, all users sign a confidentiality
agreement before being given access.
2 The Chasquis were agile and highly-trained runners that delivered messages, royal delicacies, and other objects
throughout the Inca Empire and are a source of pride in Peru.
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Figure 6.2 Main page of e-Chasqui showing all of its functions: search for patient by name (Buscar Paciente), search
for patient by sample id (Buscar Muestra), show all results entered by lab for last 2 months (Ver todas las
solicitudes), create laboratory reports (Reportes), verification of results by laboratory director (Verificaci6n), print a
batch of recently verified results (Imprimir), list of DST performed for laboratory (Consolidados de PS), quality
control page (Calidad de Datos), unverified results (Datos de Pruebas no Verificadas), export data to PHLIS
(Exportar a PHLIS), recent results for health center personnel (Resultados Recientes), and tracking samples for
health center personnel (Pruebas Pendientes).
We worked with the national and regional district and laboratory directors to define the access
profiles for the different types of users. Clinical personnel have individual access to all patients
under their responsibility, e.g. single HC, multiple HCs, or a full district. Examples of clinical
personnel include HC staff, the regional TB program director, and the regional treatment
approval committees, composed of pulmonologists and clinicians. Laboratory personnel have
both an individual and aggregate view of laboratory test results. Defining the types of access,
getting all stakeholders to agree, and building the flexibility into the system was one of the most
difficult tasks in building e-Chasqui.
The ultimate goal of the system is for all laboratories, including those at HCs, to enter tests
they've performed and use the system to order further tests. However, in the initial phase all data
were entered at the NRL and regional laboratories with "read-only" access provided to HCs.
Therefore when the first e-Chasqui laboratory receives a sample, personnel there enter all
previous test results performed on that sample.
6.2.3.1 Patient Care
The core of the e-Chasqui interface is a single patient page containing the history of all tests
performed for the patient on a left sidebar, and the details for any single sample on the main part
of the page (Figure 6.3). For a single sample, tests can be performed by up to four different
laboratories. All test results are displayed in this single page to give the full history of the
sample. This novel tracking ability is a useful addition; prior to e-Chasqui's implementation,
laboratory and clinical personnel systems lacked the test request date or the smear or culture data
when they received a DST result. The system uses a flexible search algorithm by either the
patient's names (including partial names, Figure 6.4a) or by any of the sample's test
identification numbers (Figure 6.4b). This patient page, like all others, contains only text and
uses optimized SQL queries to load quickly even in areas with low bandwidth.
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Figure 6.3 e-Chasqui main patient page which shows the patient's full bacteriological history on the left sidebar and
with bolded sample date for the sample whose results were being displayed on the main part of the pageK + 99)"
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Figure 6.3 e-Chasqui main patient page which shows the patient's full bacteriological history on the left sidebar and
with bolded sample date for the sample whose results were being displayed on the main part of the page
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Figure 6.4a Search page by patient name or partial name
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Figure 6.4b Search page by sample ID showing results
From this page, the user can select which tests to print in the official report format. Athough each
HC can print the report immediately after laboratory verification, each laboratory also prints a
copy and sends this stamped "official" report to the HC for their paper records. Due to the high
load of TB patients, the HC personnel requested the ability to view their latest results on a single
page (Figure 6.5) and track the status of all their samples being processed (Figure 6.6). Tools
were designed to meet these requirements. Finally, all HC users receive nightly email
notifications for new test results on patients attending their HC.
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Figure 6.5 Multiple results view page designed at the request of the health center personnel
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Figure 6.6 Cultures and DSTs in Process page designed at the request of the health center personnel
6.2.3.2 Laboratory Quality Control
The laboratory personnel described long-standing problems with ensuring the timeliness of
reporting results. Since a culture or DST result takes 20 to 60 days to be read, some tests "fell
through the cracks" and were not read, or were read late. Furthermore, they also requested ways
to ensure all results had been entered, to minimize duplicate tests, and to monitor the
contamination rate. Therefore, the system was expanded to incorporate quality control tools to
remind personnel to read samples on a regular basis, flag duplicate or missing results, and report
contamination rates (Figure 6.5).
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Figure 6.7 Quality control page for laboratory showing the number of DSTs without reception dates (Numero de PS
sin fecha de recepcion), DSTs in process for too long (PS que han estado mucho tiempo en proceso), number of
DSTs by proportions method that have not been entered (Numero de PS que faltan ingresar por numero correlative),
number of Griess DSTs that haven't been entered (Numero de PS Griess que faltan ingresar por numero correlative),
duplicate tests (Pruebas duplicadas), cultures in process over 60 days (Cultivos que pasaron 60 dias de proceso), and
number of cultures that have not been entered (Numero de cultivos que faltan ingresar per numero correlative).
Verification of results was also part of the current workflow in the laboratory using the paper
system. To follow this workflow, we implemented a page so that the laboratory personnel could
digitally verify results before they were communicated to the health centers, as seen in Figure
6.8.
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Finally, to ensure the timelines of entry of results by the data entry personnel at the laboratory,
prompt verification of those results by the laboratory director, and to measure the time until
health centers viewed those results, we created a page to display the average of each of those
times for any specified date as seen in Figure 6.9.
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Figure 6.9 Communication times for results
6.2.3.3 Laboratory Monitoring/Reporting
An initial reporting tool was created for the regional laboratories to view all results. Further
monitoring and reporting tools were created as the needs arose throughout the implementation
process. The type of reports can be seen in Table 6.2, below. The page to find each report can be
seen in Figure 6.10.
Table 6.2 Reports generated by e-Chasqui
Report Informed Purpose Type of Access
Frequency of e-Chasqui Regional Encourage frequent Monthly report
access by HC personnel laboratory and utilization of IS to prepared by data
TB director access real-time administrator
laboratory data
Number of laboratory Regional Identify delays in Monthly report
results entered at laboratory and data entry prepared by data
regional laboratory TB director administrator
Number of laboratory Regional Identify delays in Monthly report
results verified and laboratory and verification prepared by data
released to providers TB director administrator
DST results for any Regional and Report and identify Constant
specified period grouped INS laboratory trends in laboratory access**
by every variable in director performance
request form
Culture results for any Regional and Report and identify Constant
specified period grouped INS laboratory trends in laboratory access**
by every variable in director performance
request form
Individuals with a Regional and Report to regional Constant
positive culture for any INS laboratory TB program access**
specified date director
**Constant access means that the laboratory users could view this information in the system at
any time. Some reports let the user specify the start and end dates.
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Figure 6.10 Reports page showing how laboratory personnel can create reports of cultures performed (Generar
Reporte de Cultivos), reports of smears they have received (Generar Reporte de BKs), find negative cultures with
positive smears (Cultivos Negativos con BKs Positivos), pacientes with positive cultures (Pacientes con cultivos
positivos), and create reports of DSTs performed (Generar Reporte de Pruebas de Sensibilidad)
6.2.4 Implementation
Though described separately from the needs assessment and system design, the deployment of e-
Chasqui in the laboratories and HCs was complementary and overlapped as the use and
functionality of e-Chasqui grew.
6.2.4.1 Information Technology Assessment
The initial step of implementation consisted of an assessment of the information technology
status at each HC and laboratory, performed by the regional health districts, and included data
such as the number and condition of computers in each HC, physical security, and internet
access. The assessment identified key deficits, and we were able to coordinate with each health
district to perform corrections such as donating or fixing computers and providing or improving
internet access.
6.2.4.2 Laboratories
The commitment of the health districts was demonstrated by providing a part-time data entry
person specifically for e-Chasqui. We trained all laboratory staff in the workflow changes and in
the use of e-Chasqui during a single 1-hour group training session. We also had individualized
sessions for each user since each had different responsibilities, on average lasting approximately
1.5 hours. After several months of use, two of the three laboratories requested that the
technicians also have e-Chasqui access.
For data entry several simple design tools were implemented and found to be valuable. First, for
ease of data entry each data field can be accessed not only by clicking on the field with the
mouse, but also by sequential tabbing through the page. Second, the main patient page was
identical to the test request form from which the data entry occurred. To avoid duplicate patients
when a new patient is being created, e-Chasqui searches for patients with similar names, and if
any are found a warning is displayed where the user can click on one of the existing patient
names or click the "Create New Patient" button. Also, a tool to merge patient records was
created to handle duplicates. Duplicate sample records are handled using data quality tools,
explained previously in the Laboratory Quality Control section.
The system had to be continually expanded and adapted to the needs encountered during the pilot
phase. During the first eight months after implementation, functionality to generate lists of
reported DSTs and quality control tools were created. In the following 3 months, we added pages
for the HC users to view the tests currently being processed and a consolidated view of the last 3
weeks of results. In Sept. 2006, 11 months after initial implementation, the NRL began to use
this system and required changes to accommodate its specific workflow. At the same time we
modified the system, at HC users' request, to send only one email at night if results had been
verified that day, as opposed to an email for every result verified.
6.2.4.3 Health Centers
Once a HC had a computer with internet access that could be used by the TB personnel, all users
were trained in a single 1-hour session in computer use, confidentiality procedures, and use of e-
Chasqui. The e-Chasqui data administrator then performed follow-ups every third week. In most
HCs, we identified at least one "champion" who uses the system frequently. However, rarely did
we find this champion promoting the system to others.
Throughout the implementation, we had to troubleshoot problems. Most of the problems were
administrative or hardware related such as having to create a new windows XP user, ensuring
that HC users were viewing their results in e-Chasqui in a timely fashion, replacing a stolen
computer, and providing six web access points to TB programs within HCs that lacked computer
access (Baobab Health Partnership) 47
6.2.4.4 Controlling Permissions of System
Once a HC had a computer with internet access that could be used by the TB personnel, all users
were assigned appropriate permissions to see patients within the health centers or districts
according to the previously explained rules set with the DISAs. Figure 6.11 shows the page
within e-Chasqui used by the data administrator to set the permissions for the different users.
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Figure 6.11 Sample of page to give users permissions to health districts (top half) and to health establishments
(bottom half)
6.3 Results
The needs assessment and workflow analysis began in June 2005, with the first user testing in
July 2005, January 2006, and May 2006, for each of the two regional and the national
laboratories, respectively. Full implementation occurred in March 2006, August 2006, and
September 2006, respectively.
6.3.1 System Usage
Our system has been successfully integrated into program operations. Since its initial
implementation, 29,994 smear microscopy, 31,797 culture and 7,675 DST results have been
entered. In 2006, 99.5% of all DST results and 98.8% of all culture results for the 12 pilot HCs
were viewed online. The average number of pages viewed by the HCs in each of the two health
districts (Lima Ciudad, Lima Este) can be seen in Figure 6.12. The large increase in pages
viewed in August 2006 occurred because e-Chasqui was fully implemented in both the Lima
Este regional laboratory and the NRL.
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Figure 6.12 Average monthly number of pages viewed by health centers in each of the
implementation occurred in March 2006 (Lima Ciudad) and August 2006 (Lima Este).
two health districts. Full
This is an online transaction processing system and since it is used in sites with low to medium
internet bandwidth, this is a major factor in its performance. Due to e-Chasqui's simple, text-
based design all sites can use it during routine clinical and laboratory work. In 2006, the system
performed on average 1865 transactions per day including page views, data entry, and analysis.
In 2007, it has increased to 4501 daily transaction and the system's performance has not been
appreciably affected.
Feedback from users has been positive. This feedback has been in the form of conversations by
the research staff with the clinical and laboratory personnel, increased usage of the system by
intervention sites, and requests for expansion of the use of the system by the district and
laboratory administrators. Importantly, we have been careful to respond to critical comments and
suggestions to enhance the system and maintain user "buy-in." A strong indicator of the system's
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utility is that district administrators have requested expansion of the system to additional
institutions. In response, we are expanding access to three laboratories, 2 hospitals and 11 HCs
that administer 47 other health centers. In total, e-Chasqui will serve a network of institutions
providing medical care for over 3.1 million people.
6.3.2 System Costs
In quantifying the costs of designing and implementing this web-based system in Peru, we have
found the annual recurring cost to be US$34,738 total or US$0.53 per sample entered. More
details can be found in Table 6.3. This figure includes the cost of full internet access to all e-
Chasqui institutions and a US based system manager. Since HCs use the internet for other
purposes, including the national health register, we feel the system should incur 50% of the
internet cost. Also, if the system manager were Peruvian with a local salary, the annual recurring
cost would reflect the approximate cost of implementing e-Chasqui in all major health centers in
the two health districts. For comparison, the e-Chasqui health districts had 1103 MDR-TB
patients on standardized or individualized treatment in 2006. The annual cost of these treatments
are approximately US$2,900 and US$3,000, respectively' 94. Another comparison is that these
health districts accounted for 53% of TB and MDR-TB patients in a national program whose
2006 budget was close to US$10 million'95. In either case, this system to communicate all vital
laboratory data for TB and MDR-TB treatment accounted for approximately 1% of the budget
for those districts.
Table 6.3 Fixed and monthly costs of implementing e-Chasqui
Calculation Fixed Cost Monthly Cost
Infrastructure Building
Computers, web access points and installation 8 x $458 (average cost) $3,666.00
Printers 4 x $150 $600.00
Server $2,500.00
Internet for health centers and labs 12 HCs & 2 labs x $41 monthly $574.00
Internet for headquarters with server 1 HQ x $400 monthly $400.00
Total $6,766.00 $974.00
System Design & Development
Peruvian Clinician 80 hours x $21/hour $1,680.00
System Manager 500 hours x $22/hour $11,000.00
Faculty Consulting 40 hours x $59/hour $2,360.00
Programmer 100 hours x $40/hour $4,000.00
Total $19,040.00
System Implementation
System Manager 620 hours x $22/hour $13,640.00
Faculty Consulting 80 hours x $59/hour $4,720.00
Programmer 450 hours x $40/hour $18,000.00
Total $36,360.00
Data Entry & Management
System Manager 1/4 time $937.50
Peruvian Data Administrator 2/3 time $253.33
Peruvian Data Entry (one per lab) 3 x 2/3 time $580.00
Transportation for Data Administrator 1.5 monthly visits to every site $150.00
Total $1,920.83
System Advocacy
Peruvian Clinician 100 hours x $21/hour $2,100.00
Faculty Consulting 50 hours x $59/hour $2,950.00
System Manager 200 hours x $22/hour $4,400.00
Total $9,450.00
Grand Total $71,616.00 $2,894.83
We have divided the costs into five categories: infrastructure building, system design and development, system
implementation, data entry and management, and system advocacy. For infrastructure, the objective is to have every
health institution with a computer, printer and intermittent, if not constant, internet connection. System advocacy has
consisted of meetings and discussions, usually with national or regional administrators, to discuss the system's
potential benefits, provide updates on its status, and train users on the system's abilities since this was the first time
a web-based clinical system had been implemented. The costs incurred by a new program implementing e-Chasqui
should be reduced as they will not include system development.
All costs are in 2007 U.S. Dollars.
Unless explicitly stated all staff are US based.
6.3.3 Additional Benefits
Several additional benefits were seen in implementing this information system. The first was the
ability to survey the clinical staff at the health establishments. The first implementation of this
was a questionnaire to find out why duplicate DSTs were ordered for the same patient. The
Peruvian National norm states that a second DST should not be ordered for a patient within 6
months of the sample being taken for the first one unless there is a relevant clinical reason for it.
Currently, the Reference Laboratories perform duplicate DSTs for the same patient within this 6
month period. The system e-Chasqui was able to quantify the number of duplicate DSTs
performed, something previously unavailable from the paper system. To investigate the reasons
why the e-Chasqui pilot health centers order multiple DSTs an online survey was implemented.
When a laboratory entered a duplicate DST within e-Chasqui, an email was sent to all the
personnel at the health center to fill out the online survey. The email survey displayed the
previous DST results and their current request (Figure 6.13). It also asked the user to check the
reason they had ordered this duplicate DST. The choices were:
1. When I ordered the DST, I didn't know that a DST was currently being performed
2. The result of the first DST doesn't agree with the clinical status and/or radiologic
findings of the patient
3. Patient has worsened clinically and deserves a second DST
4. There are different results for DST ordered previously
5. I have not received the first DST result
6. I have a Griess result which shows resistance
7. I do not know who ordered this DST
8. Other, please specify
I X43 fUS-MUar- 2 .UU/ .. . .. an Juan de Amancaes 117-Abr-2UU71 1Agr enpa (
Por favor, indique la raz6n por que solicit6 la prueba de sensibilidad reciin ordenada
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S1. Cuando solicte la prueba de sensibilidad, desconocia que habia tra corniendo o hecha anterormente
03. El paciente ha deteriorad clinicamnte y amrita na segunda prba de sensibilidad
5. El resultado de la primera prueba de sensibilidad no me ha legado
[07 Desconozco quien soicit6 esta prueba de sensibilidad
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Figure 6.13 Example of online survey sent to health center personnel when a duplicate DST was entered into e-
Chasqui
During the 10 month study period, 178 of the 180 surveys sent were answered (98.9%). Of those,
37 were answered by the TB program clinician, 137 by the nurse or nurse assistant, and 4 by the
laboratory technician. The responses to these surveys can be seen in Table 6.4. Of the 178
responses, 106 (59.6%) were not clinically appropriate for a second DST. They are highlighted
in Table 6.4.
Table 6.4 Results of online survey
Answer Number Percentage
Not Aware of other DST 16 9.0%
DST inconsistent with patient
status 19 10.7%
Patient Clinically Worse 42 23.6%
Conflicting previous DSTs 2 1.1%
DST results not received 23 12.9%
Resistant Griess Result 9 5.1%
Don't know who ordered DST 28 15.7%
Other
- Want 2nd line results 5 2.8%
- New treatment 9 5.1%
- Multiple sample to get results 4 2.2%
- Patient has a TB contact 5 2.8%
Other 16 9.0%
Total 178 100.0%
Additionally, during the pre and post survey period, 25 and 35 DSTs were not processed,
respectively, because the lab personnel at the laboratory checked that there was a previous DST
within e-Chasqui.
Another benefit of the system was the ability to perform operational research to improve the
work of the laboratory and provide data for academic publications. Due to e-Chasqui, we have
been able to implement quality control tools within the laboratory and perform real-time
assessment of the performance of a novel, rapid DST, the Griess method, using programmatic
data from the reference laboratory and the Peruvian Instituto Nacional de Salud (National
Institute of Health).
6.4 Discussion
6.4.1 Challenges and Obstacles
Creating a system with enough flexibility to meet all stakeholders' needs that arise during
implementation. Though e-Chasqui has focused functionality, the need to create many types of
users and to define methods of communication between institutions took much work and time.
There were two main reasons for this. First, the inexperience in implementing clinical
information systems among stakeholders meant much learning about this topic had to take place.
As a result, the technical requirements of e-Chasqui were constantly revised. For example, some
stakeholders were unfamiliar with the concept that different users see information in specific
manner such as individual or aggregate views. Therefore some exhibited initial skepticism about
the system's ability to keep information confidential. Second, defining appropriate user accesses
was a balance between patients' confidentiality and the users' informational needs. Again due to
e-Chasqui's novelty, both the developers and the institutions have had to learn what the
appropriate user permissions were. The web-based architecture allows e-Chasqui to track all
users' actions. This capability was highly valued by all stakeholders since many of them asked
about data confidentiality and security.
Maintaining both high data quality and timeliness with limited staff. The balance between
opportune entry of results and electronic verification with high data quality continues to be a
problem. The mean number of days between a DST result being read, its entry, and verification
is 5.8. Though we believe that the additional step of result verification ensures higher data
quality, we are still working to minimize these delays. On the other hand, the average number of
days from laboratory verification to the HC personnel viewing their result in e-Chasqui is 2.2
which shows their interest in updated results.
Strengthening public infrastructure. To ensure e-Chasqui had lasting impact on patient care, it
was necessary to integrate this system within the public health structure. This can mean
additional work in terms of agreements with the different national and regional institutions, as
well as providing additional services. However, the long lasting benefits, such as sustainability
and implementation at a national level, usually outweigh this additional work.
6.4.2 Lessons learned
TB programs trying to improve communications, monitoring, and patient care by implementing
electronic information systems face a task that can sometimes seem overwhelming. We have
learned several lessons from our experience developing a nation-wide electronic laboratory
information system in Peru.
All important stakeholders must contribute to the design and implementation. This is the
only way to ensure the system addresses the actual user needs and to have user appropriation. To
identify key system attributes during the design, medical and laboratory personnel must be
involved from the beginning. Furthermore, developers must create a system easily integrated into
the existing workflow with minimal disruption and sufficient advantages to gain "buy-in" such
as easy usage for people with little computer experience. Lastly, branding the system
appropriately, perhaps with a familiar name, makes it more recognizable. During the system's
implementation, users must be constantly asked if they have questions or problems and their
suggestions for fixing them. Problems that are outside the system's scope, such as not having
access to a computer with internet, personal conflicts with other personnel who would like
internet access, or equipment failures, should be addressed with administrative personnel.
Political support is integral to the system's dissemination. Unless there is will from the
administration to implement an electronic information system, promote its use, and allocate
resources to maintain it, there is little chance of success. This system was implemented as part of
a scale up strategy between the National Tuberculosis Program and NRL to expand the
laboratory network. Political support in this case was demonstrated by the support of the regional
health administration and by laboratories providing data entry staff.
Provide adequate training in the system's use and benefits. Training should be focused on the
benefits that it provides to the users. In Peru, most previous health information systems have
required HC personnel to enter data for reporting purposes without receiving any feedback.
While implementing e-Chasqui, we saw reticent users become enthusiastic when they realized
the system would provide them with useful information. Training must also be provided
continually, and the system's use monitored to ensure it continues to meet user's needs.
Ensure the system's sustainability. Sustainability in our experience is maintained by generating
user confidence in the system's quality and usability, creating a flexible system able to adapt to
changes within the public system, and providing evidence of system benefits. To have user
confidence, the system must actually save time and be perceived as a consistently useful tool
after the initial novelty has worn off. Three main factors to promote sustainability include (1)
providing and maintaining a functional internet access point at their HC, (2) ensuring the quality
and promptness of data, and (3) providing support to all users. Support to all users usually took
the form of technical assistance at the laboratories and up-to-date results to HCs.
Implement the system as part of a larger structural improvement. We believe that the
implementation of an information system is enhanced if it is an integral part of larger
improvements in the clinical or laboratory infrastructure. That way the system can not only help
improve communication but also be part of a more general improvement in workflow. In the case
of e-Chasqui, it was incorporated into national project to decentralize DSTs.
6.5 Conclusions
Electronic laboratory information systems have much potential to improve patient care and
public health monitoring in resource-poor settings. Some of the challenges described, such as
lack of trained personnel, limited transportation, and large coverage areas, are obstacles that a
well-designed information system can overcome. However, creating well-designed information
systems is a difficult task necessitating appropriate resources, expertise and time to be
successful.
e-Chasqui has the potential for creating a national TB laboratory network in Peru to facilitate the
communication and analysis of all bacteriological results country-wide. We have already begun
to see additional benefits to this system such as having the test always available during clinical
decision making, reducing duplicate tests performed, and reducing the time and money spent by
staff checking the status of their samples. Studies have been initiated to quantify these benefits.
We are also conducting a prospective and retrospective evaluation study to measure e-Chasqui's
effect on reducing mean delays, "lost" results with excessive delays, and errors of laboratory
reporting. Furthermore, this same system or one similar could more easily be implemented in
other countries facing similar problems of test tracking. In our efforts to make these systems
available, we are implementing the core functionality of e-Chasqui as a module in the OpenMRS
system96 197. With colleagues in the US and Africa, we have developed OpenMRS, a general
purpose medical record system architecture to support TB and HIV treatment programs.
OpenMRS is being rolled out in eight countries' 98 with support from the US Centers for Disease
Control and Prevention and the World Health Organization.
7 Impact of e-Chasqui on Delays
This chapter describes the evaluation performed on e-Chasqui described in the previous chapter.
This chapter focuses on the impact of e-Chasqui in the time to communicate results between
laboratories and health centers, to place a patient on an appropriate MDR-TB regimen, and to
have patients become culture negative after a drug resistant DST result.
7.1 Introduction
Laboratory information systems in developed countries have been shown to decrease turn-
around-times (TAT) of laboratory results, 99-201 reduce redundancy in resource utilization,200 202
203 and provide faster and more complete notification for public health purposes. 3 4 136 204 Shorter
TATs have been associated with decreased treatment time, mortality, morbidity, and length of
hospital stay.205 206 However, a systematic review found no reports of evaluations of these
systems in resource-poor settings.7
We conducted a cluster randomized controlled trial to evaluate the effectiveness of the e-Chasqui
laboratory information system in reducing delays within the TB program in Peru. We also
performed a before-and-after comparison to evaluate additional effects of the system.
7.2 Methods
A cluster randomized controlled trial (RCT) tested the effect of the laboratory information
system e-Chasqui in reducing the time to communicate patients' test results, start them on
appropriate treatment, and have them culture convert. The trial is reported according to the
CONSORT statement. 20 7 As a secondary study design, we also conducted a before-and-after
trial. Both trials were performed within a larger observational study evaluating the impact of
expanded laboratory capacity in the district laboratories.' 5 All data for both the RCT and before-
and-after trials was collected prospectively.
7.2.1 Study Settings
This study was carried out in two health districts of Lima, Peru: Lima Ciudad and Lima Este.
Lima Ciudad includes 45 health establishments (24 HCs, nine health posts, and 12 hospitals)
serving a population of 1,577,090 in an area of approximately 100 km 2. Lima Este includes 134
health establishments (42 HCs, 87 health posts, and 5 hospitals) serving a population of
1,088,515 in an area of approximately 6340 km2. Smear microscopy is used to diagnose active
TB, while culture and DST are reserved for individuals with confirmed TB and at least one risk
factor for MDR-TB according to National Tuberculosis Program (NTP) Norms.28 Smear
microscopy is performed in Level I laboratories in HCs and hospitals. Health posts send sputum
samples to their closest HC for smear microscopy. For patients with MDR-TB risk factors,
smear-positive samples are sent to the district Level II laboratory for culture and/or 1st line DST
(Table 7.1). DST results resistant to isoniazid or rifampicin or both are sent to the NRL for 2nd
line DST. Results on paper are sent from the NRL back to the district laboratory for registration
and subsequent transmission, directly or indirectly, to the point-of-care health centers and posts.
The patient is then routinely seen by a pulmonologist at the local hospital to review the DST
results and if necessary modify the TB regimen. In patients with drug-resistant isolates, an expert
committee reviews the case to approve enrollment into MDR-TB therapy (Figure 7.1).
Table 7.1. Number of tests performed annually in district laboratories using e-Chasqui
2003 2004 2005 2006 2007 2008
(anticipated)
Cultures
Lima Este 5,416 6,981 6,037 6,960
Lima Ciudad 8,256 8,288 9,611 10,168 11,784 12,833
DSTs
Lima Este 0 0 0 493 1,645 2,807
Lima Ciudad 0 0 946 1,893 2,721 3,514
The two health districts organize transmission of paper results to HCs differently. In Lima
Ciudad, all 24 HCs are "direct HCs" that receive results directly from the laboratory and present
patients to the district MDR-TB treatment committee, which determines the treatment plan. In
Lima Este, 17 direct HCs use the identical process as HCs of Lima Ciudad. The other 25 HCs
and 87 health posts are "indirect HCs" whose results are communicated to one of the 17 direct
HCs, which in turn sends results to the indirect HCs. The indirect HC then compiles and submits
patient information to the direct HC, which presents the case to the MDR-TB treatment
committee for development of a treatment plan, which the direct HC returns to the indirect HC
for treatment initiation (Figure 7.1).
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7.2.2 Study Design
e-Chasqui was implemented at two levels: at the district & national laboratories and at the health
establishments. First, the system was implemented at the two district laboratories and NRL.
These laboratories served all of the health establishments. After full implementation in the
laboratories, 12 of 32 HCs were randomized to utilize e-Chasqui. The cluster RCT evaluated the
effect of HC access to e-Chasqui. Because randomization did not occur at the laboratory level,
we used a before-and-after analysis to evaluate the effect of district laboratory access to the
system.
We prospectively collected baseline data for 12 months from the two health districts. We then
implemented e-Chasqui in the laboratories and randomly assigned six HCs from each health
district (12 total) to the intervention (Figure 7.2). In Lima Ciudad, these six were randomized
from the 20 highest incidence HCs. In Lima Este, they were randomized from the 12 direct HCs
within Lima city limits. Indirect HCs (n=44) belonged to the study arm that was assigned to their
corresponding direct HC (Figure 7.1). Therefore, the six direct intervention HCs in Lima Este
had 17 indirect intervention HCs and the 6 direct control HCs had 27 indirect control HCs (Table
7.2). After the intervention was implemented, we collected data on the same endpoints in both
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control and intervention arms. The Lima Este district laboratory did not perform DSTs before the
implementation of e-Chasqui, hence there is no pre-implementation data for that district.
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Figure 7.2 Cluster randomized controlled trial schema with before and after comparison
During the study (October 2006), the Lima Este health district re-organized their HCs. All direct
intervention HCs remained the same. One direct control HC was re-allocated to an indirect
intervention HC, three indirect intervention HCs to indirect control HCs and three indirect
control to indirect intervention. The samples and patients in these "cross-over" HCs maintained
their original assignment in the analysis since it only affected 17 data points for the primary
outcome. Patients in the study were assigned to the HC where they were first captured. If a
patient transferred or left a sample at another HC, they and their sample would be assigned to the
initial HC. If a patient transferred from a control to an intervention HC, the intervention HC staff
would have access to all of that patient's bacteriological history in e-Chasqui. Both of these
problems may have the effect of weakening the impact of the intervention.
This study was approved by the Partners Healthcare Human Research Committee and the
Peruvian National Institute of Health.
7.2.3 Study Population
All individuals who lived within the catchment area of one of the two district laboratories and
had at least one MDR-TB risk factor as defined by the Peruvian NTP Norms were included in
this study.28 For Lima Ciudad, only individuals in the 20 HCs with highest incidence were
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included. For Lima Este, only tests performed for the 12 direct HCs within Lima city limits (and
their respective indirect HCs) were included. There were no exclusion criteria for enrollment into
the study. Because all sputum samples of patients who have at least one MDR-TB risk factor are
sent to the district laboratory for DST, subjects eligible for enrollment into the study were
identified by this referral.
7.2,4 Outcomes
The primary outcome of the study was the laboratory turn-around-time (TAT), defined as the
number of days between a test result date and the date that result was received by the HC (Table
7.2). For the electronic system, the date received at the HC was the earliest of the reception of
the paper result or when the result was viewed online by a TB staff member. This primary
outcome was calculated for both cultures and DSTs. Secondary outcomes were: (1) the
proportion of DST results with a laboratory TAT greater than 60 days among all samples
requested and emitted to the same health establishment, and (2) treatment TAT, defined as the
number of days between the result date of the first DST resistant to INH, RIF or both and the
date of a new regimen or change in regimen (Figure 7.3).
Table 7.2 Outcome definitions and sample
Outcome Definition Sample
Culture Lab TAT Number of days between a culture result date and All cultures performed on
the date that result was received by the HC participants belonging to study
clusters
DST lab TAT Number of days between a DST result date and All DSTs performed on
the date that result was received by the HC participants belonging to study
clusters
DST lab TAT > The proportion of DST results with a laboratory All DSTs performed on
60 days TAT greater than or equal to 60 days participants belonging to study
clusters
Treatment TAT Number of days between the result date of the All patients with a DST
first DST resistant to INH, RIF, or both and the resistant to INH, RIF, or both
date of a new regimen or change in regimen
Culture Number of days between the result date of the All patients with a DST
conversion TAT first DST resistant to INH, RIF, or both and the resistant to INH, RIF, or both
sample date of the first of two negative who had a positive culture six
consecutive cultures taken at least 30 days apart month before or two months
after the DST result date
Although the study was not designed to have sufficient power to detect differences in time to
culture conversion, we collected data on the culture conversion of patients. We calculated the
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number of days between the result date of a DST resistant to INH, RIF, or both and the date of
the first of two negative consecutive cultures taken at least 30 days apart (culture conversion
TAT).208 Patients in this cohort must have had a positive culture six months before or two
months after the DST result date.
Culture Conversion TAT
Treatment TAT
DST Lab TAT
Treatment SampleSample DST Health center Evaluation Treatment Samplestart or collection of
collection result reception by clinician change 1St of 2
negative
cultures
Figure 7.3 Diagram of turn-around-time (TAT) outcomes
7.2.5 Intervention
We designed and implemented the web-based laboratory information system "e-Chasqui" that
was described in Chapter 6.127 It was deployed in the NRL, two district laboratories, and 12
intervention HCs.
7.2.6 Sample Size
Previously we measured the treatment TAT to be approximately 65 days.15 Assuming that the
effect estimate of e-Chasqui would reduce this delay by 20 days, based on 0.8 power, and an a of
0.05, 165 subjects in each group (330 total) were required.
7.2.7 Usability and Acceptability of System
An anonymous survey previously used in Peru 80 was applied to measure the usability and
acceptability of the system. The survey was modified for our intervention and validated with
employees from our organizations, Partners In Health and Socios en Salud. After the intervention
was completed, HC personnel with e-Chasqui access were given the same survey as those
without access with two additional sections for questions about e-Chasqui. When personnel
without access were asked about an electronic system the question referred to "an electronic
laboratory information system" and not specifically to e-Chasqui. The responses were multiple
choice, short answers or given on a five-point Likert scale anchored by 1=very positive, 5=very
negative. The survey examined two themes: the frequency of missing results in the paper and e-
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Chasqui systems and the security of both systems. Examples of both the control and intervention
HC questionnaire can be found in Appendix B.
7.2.8 Data Abstraction
Baseline data were collected 15 months prior to the implementation of e-Chasqui (Jan 1, 2005-
Mar. 30, 2006 for Lima Ciudad, May 1, 2005-Aug. 18, 2006 for Lima Este). Data were
prospectively abstracted by a team of trained collectors who used standardized forms. For the
RCT the study period started on the date of implementation of e-Chasqui and ended on August
31, 2008. Data are included from only those laboratories that implemented e-Chasqui (the NRL
and the two district laboratories). Equivalent variables between the e-Chasqui and the study
database were compared for data quality. Discordant results were verified at the laboratory that
had emitted the result. If the end date for any TAT was missing, we censored that time using the
date the patient left the study.
7.2.9 Statistical Analysis
We examined the effect of the intervention at a sample and an individual level, adjusting for the
impact on variance of the clustering in the study design. We used multivariate regression models
(marginal model with generalized estimating equations) to investigate the effect of the
intervention on the TAT outcomes as a function of covariates and to account for the clustering at
the HC level. 209 To investigate whether the intervention was associated with a reduction in the
number of DST results with laboratory TAT greater than 60 days, we used a generalized linear
mixed model "84 185 with HC as a random effect and health district and period (pre- and post-
implementation) as fixed effects.
Due to the different structures of the laboratory and HCs within each district, we stratified our
analysis by the health district (Lima Este and Lima Ciudad). For Lima Este, we further stratified
by type of HC (direct or indirect). All stratification was done in the cohorts and not in the
multivariate models. To adjust for possible HC differences that may have been unequally
distributed despite randomization, we included the median pre-intervention TAT per HC for each
of the TAT outcomes (as a proxy for HC variance) and number of HC staff changes. At the
individual level for the treatment and culture conversion TAT, we also adjusted for HIV status
and pediatric status.
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To analyze the differences in the means of survey responses we used a t-test for two independent
samples with the Satterthwaite's approximation for the degrees of freedom because of the
unequal variances between the groups. We used SAS version 9.1 (SAS Institute, Cary, NC,
USA) for all analysis and checked all models using R.210
7.3 Results
During the trial, 89% (1671/1888) of all eligible patients were enrolled (Figure 7.4). The
intervention HCs had a significantly greater number of study participants per HC. If separated by
district, these differences existed only in Lima Ciudad. The intervention HCs also had younger
patients, a higher proportion of female patients, and a larger number of personnel changes in the
TB clinician per HC. There were no significant differences in the number of patients per indirect
HCs, number of co-infected with HIV, number of TB nurse changes during the study, number of
patients who had a smear or culture positive or had a drug resistant DST by study arm (Table
7.3). 98% of all culture results and 100% of all DST results available in e-Chasqui were viewed
by the intervention HCs.
Treatment
TAT
Culture
Converslor
TAT
Figure 7.4 Flow of participants (npts), cultures (n) and DSTs (nDST) through trial
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Table 7.3. Characteristics and outcome measures for all study health centers (HCs) and participants. Values are
mean (SD) unless stated otherwise.
Characteristic Control Intervention p-value
Total # direct HC 22 12
Total # indirect HCs 27 17
Total # (%) participants in Lima Ciudad 357 (46) 462 (52)
Total # (%) participants in direct HCs 548 (70) 650 (73)
Total # (%) participants in indirect HC 233 (30) 240 (27)
Participants per HC 16.3 (16.9) 29.7 (32.6) 0.04
Participants per direct HC 26.1 (18.2) 54.2 (39.1) 0.02
Participants per indirect HC 8.6 (10.9) 13.3 (10.5) 0.10
Smear or culture positive patients per HC 12.8 (13.7) 23.7 (29.5) 0.08
Patients with drug resistant DST per HC 4.9 (4.8) 8.3 (11.7) 0.73
Age (years) 33.5 (16.0) 31.1 (16.5) 0.001
Total # (%) female 257 (33) 340 (38) 0.02
Total # (%) co-infected with HIV 100 (13) 94 (11) 0.15
Changes in TB clinician per HC during 2.1 (1.1) 1.7 (1.1) 0.04
study
Changes in TB nurse per HC during study 1.6 (0.9) 1.4 (0.9) 0.34
7.3.1 Laboratory TAT
Intervention HCs took significantly less time to receive both DST (median 10 vs. 18 days,
p<0.001) and culture (5 vs. 8 days, p<0.001) results (Table 7.4, Figure 7.5). For cultures, the
same pattern is seen where direct HCs in both districts have lower laboratory TATs (Lima
Ciudad p<0.001, Lima Este p=0.004), but indirect HCs have a higher TAT (9 vs. 8 days,
p=0.02). For DSTs, the district with all direct HCs (Lima Ciudad) had a significantly lower TAT
(median 9 vs. 16 days, p<0.001). In Lima Este, it was significantly lower for direct HCs (14 vs.
19 days, p<0.001), but not for indirect HCs (27 vs. 22 days, p=0.658). For the analysis of DST
laboratory TAT, diagnostic plots of the marginal model showed that it did not fit the data well.
To confirm the results for that outcome, we performed the same analysis using a mixed effects
model with only the uncensored data. This model provided approximately the same estimate and
p-value as the marginal model. For all other outcomes, the marginal model diagnostic plots
showed a good fit.
Table 7.4 Primary and secondary outcomes with stratification factors of health district and HC type. Figures are
median (IQR) unless stated otherwise.
Outcome Control Intervention Adjusted p-value
HCs HCs Hazard Ratio
(95% CI)
Culture laboratory TAT 8 (6) 5 (5) 0.64 (0.60-0.67) <0.001
Lima Ciudad 8 (6) 4 (4) 0.50 (0.47-0.53) <0.001
Lima Este direct HCs 7 (8) 4 (6) 0.59 (0.48-0.73) 0.004
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Lima Este indirect HCs 8 (10) 8 (11) 1.36 (1.17-1.56) 0.02
DST laborator TAT 18 (23) 10 (15) 0.60 (0.55-0.67) <0.001
Lima Ciudad 16 (18) 9 (13) 0.54 (0.48-0.61) <0.001
Lima Este direct HCs 19 (26) 14 (26) 0.62 (0.42-0.93) 0.004
Lima Este indirect HCs 22 (31) 27 (32) 1.07 (0.76-1.49) 0.658
% of DST laboratory TAT > 60 days 17.7 7.9 0.51 (0.27-0.97) 0.04
Lima Ciudad 13.2 4.0 0.26 (0.13-0.52) <0.001
Lima Este direct HCs 18.9 12.1 0.33 (0.08-1.48) 0.122
Lima Este indirect HCs 32.3 35.4 1.07 (0.37-3.09) 0.901
Treatment TAT 50.5 (62) 66 (71) 0.92 (0.63-1.33) 0.539
Lima Ciudad 40 (57) 66 (64) 0.98 (0.61-1.58) 0.882
Lima Este direct HCs 69 (57) 70 (125) 0.36 (0.09-1.5) 0.161
Lima Este indirect HCs 48.5 (169) 24 (97) 1.63 (0.63-4.2) 0.31
Culture conversion TAT 85.5 (81.5) 67.5 (96) 0.61 (0.38-0.99) 0.043
Lima Ciudad 85.5 (79) 70 (79) 0.82 (0.48-1.4) 0.473
Lima Este 54 (100) 19 (10) 0.18 (0.04-0.72) 0.015
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Figure 7.5 Kaplan-Meier survival curve for DST laboratory TAT for RCT showing first 200 days
In the before-and-after comparison, all HCs in the district had a significantly lower TAT post
implementation overall (6 vs. 8 days, p<0.001), in Lima Ciudad (6 vs. 7 days, p<0.001), Lima
Este direct HCs (5 vs. 9 days, p<0.001), and Lima Este indirect HCs (8 vs. 12 days, p<0.001).
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For DSTs, Lima Ciudad (12 vs. 15 days, p=0.02) also had a significant decrease post-
implementation.
7.3.2 Laboratory TAT > 60 days
Intervention HCs had significantly less DSTs that had a laboratory TAT over 60 days compared
to control HCs (p=0.04). There was a significant decrease in Lima Ciudad (4.0 vs. 13.2%,
p<0.001), but not in Lima Este direct HCs (12.1 vs. 18.9%, p=0.122) or indirect HCs (35.4 vs.
32.3%, p=0.901). 57.5% (42/73) of DST with laboratory TAT over 60 days never arrived
compared with 83.6% (112/134) for the control HCs. In the before-and-after comparison, the
decrease after the implementation for the full cohort (12.4 vs. 24.9%) and in Lima Ciudad (7.8
vs. 15.4%) were both highly significant (p<0.001).
7.3.3 Treatment TAT
For a total of 210 participants (109 in the intervention HCs, 101 in the control) treatment TAT
did not significantly differ in the intervention versus control HCs: overall (median 66 v. 50.5
days, p=0.539), in Lima Ciudad (median 66 vs. 40 days, p=0.882), in Lima Este direct HCs (70
vs. 69 days, p=O.161), or in Lima Este indirect HCs (24 vs. 85 days, p=0.31) compared to control
HCs (Figure 7.6). In the before-and-after comparison, there was a significant decrease overall
(60 vs. 62 days, p=0.014), but not within any of the stratifications: Lima Ciudad (59.5 vs. 52
days, p=0.09), Lima Este direct HCs (70 vs. 68 days, p=0.383), Lima Este indirect HCs (24 vs.
48 days, p=0.44).
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Figure 7.6 Kaplan-Meier survival curve for treatment TAT for RCT showing first 400 days
7.3.4 Culture Conversion TAT
Among 193 participants included in analysis for culture conversion TAT (102 in intervention
HCs, 91 in control), those in the intervention HCs had a significantly lower TAT than those in
the control HCs for the full cohort (p=0.043) and in Lima Este (19 vs. 54 days, p=0.015), see
Figure 7.7. In Lima Ciudad there was no significant difference (70 vs. 85.5 days, p=0.473).
Since there were only seven patients in Lima Este, we did not stratify by HC type. In the before-
and-after comparison, there was a significant increase in culture conversion TAT overall (70 vs.
37 days, p<0.001) and in Lima Ciudad (76 vs. 35.5 days, p<0.001). The opposite, however, was
seen in Lima Este (19 vs. 38 days, p<0.001).
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Figure 7.7 Kaplan-Meier survival curve for culture conversion TAT for RCT showing first 400 days
7.3.5 Usability and Acceptability of System
The response rate among intervention HC users administered the survey was 94% (29 of 31). 23
users were not administered the survey because they were not present at their HC during the
visit. The response rate among control HC users was 93% (108 of 116). Of the intervention HC
users, 48% (n=14) were clinicians or nurses in charge of the patients treatment (Table 7.5). The
intervention HC users had, on average, more years of internet usage and had accessed the
internet more frequently from the TB office or laboratory. Both of these can be attributed to e-
Chasqui since the survey was given after three years of using the system and the district office
had prioritized internet access for those TB offices in intervention HCs.
Table 7.5 Survey respondent characteristics
Controls Intervention
Characteristic (n=108) (n=29)
Gender
Male 27 (25) 12 (41)
Clinical background
Physician 20 (19) 6 (21)
Nurse 35 (33) 8 (28)
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- Control HCs
- Intervention HCs
9 (8)
36 (34)
5 (5)
26 (25)
47 (44)
25 (24)
1 (1)
Laboratory staff
Nurse technician
Other
Years of Internet usage
0
1-5
6-10
>10
Location of Internet usage
TB office/laboratory
Office in health center
House
Internet cabin
Other office
Other
Health district
Lima Ciudad
Lima Este
16 (15)
17 (16)
56 (53)
36 (34)
17 (16)
3 (3)
88 (83)
17 (16)
3 (10)
10 (34)
2 (7)
2 (7)
18 (62)
6 (21)
1 (3)
15 (52)
4 (14)
12 (41)
7 (24)
3 (10)
0
17 (59)
12 (41)
Even though intervention HC users were more satisfied with the paper system than the control
HC users (p=0.005), they still preferred e-Chasqui (p=0.009). Users liked all tools provided in
e-Chasqui with nightly email notification of results and easy access to the system being the
favorites. Of the clinical users, 71% (10 of 14) used e-Chasqui in the presence of their patient at
least a quarter of the time. The same number reported at least one in 10 patients expressing to
them an unsolicited positive opinion about the system. When asked about a nation-wide
implementation, all e-Chasqui users thought it appropriate to expand the system and that it would
improve the quality of patient care.
Table 7.6 User satisfaction with paper and e-Chasqui systems and opinion on a national TB laboratory information
system. Responses are mean of five-point Likert scale anchored by 1=very positive, 5=very negative or number
(percentage) of option chosen
Question
How satisfied are you using the paper system to communicate
results?
How satisfied are you using e-Chasqui to communicate results?
Which system do you prefer to view your results?
e-Chasqui
Paper
Both are the same
How many times do you access e-Chasqui?
Multiple times daily
Controls Intervention
(n= 108) (n=29)
3.0 2.2
1.4
20 (69)
1 (3)
6 (21)
3(10)
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Once daily 10 (34)
Once weekly 8 (28)
Once monthly 5 (17)
Almost never 2 (7)
Benefit of (mean of responses, 1=Very Beneficial, 5=No
Benefit)
Email notification of results 1.11
List of pending tests 1.32
View my patients' results from other health centers 1.28
Easy access 1.15
Do you use e-Chasqui during patient visits? (n= 14 clinical users)
More than half of patients 8 (57)
Less than half 2 (14)
Less than a quarter 1 (7)
Very few 2 (14)
Never 1 (7)
If so, what quantity of patients have expressed that they find e-
Chasqui beneficial? (n= 14 clinical users)
1 of 2 patients 5 (36)
1 of 4 2 (14)
1 of 10 3 (20)
1 of 50 1 (7)
1 of 100 1 (7)
None 1 (14)
Is it feasible to implement a web-based system to communicate
lab results at a national level?
Yes 102 (96)
No 1 (1)
Would this system improve patient care?
Yes 101 (95)
No 1 (1)
Do you think it appropriate to expand e-Chasqui to other health
districts?
Yes 29 (100)
No 0
How do you think using e-Chasqui in other health districts
would impact the quality of care of patients?
Improve greatly 25 (86)
Improve a bit 3 (10)
Neither improve nor worsen 0
Worsen a bit 0
Worsen greatly 0
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7.4 Discussion
The e-Chasqui laboratory information system considerably reduced the time to communicate
results of cultures and DSTs to local HCs and the proportion of results that had an excessive
delay or never arrived. The patients in the intervention HCs had the same time to treatment as
those in control HCs, but they did have a significant decrease in the time until they culture
converted.
The prospective, randomized nature of this trial allowed for rigorous evaluation of the effect of
e-Chasqui within the National TB Program. There have been no prior evaluations reported of the
impact of an electronic system in decreasing delays in a resource-poor clinical setting and the
results of this study show that it can have a large effect in the communication time of critical
laboratory data. This effect might be even more apparent if this system were used in rural areas
since the obstacles to communication usually encountered (long travel times, infrequent
transport, or weather) are easily surpassed if there is a reliable internet connection. Perhaps more
importantly, the system prevented results from arriving too late or never arriving. We found that,
without e-Chasqui, approximately 1 in 8 DST results arrived late or never arrived at the HC
before our intervention. This means that without a system like e-Chasqui, of the approximately
950 MDR DST results performed in 2008 by the district labs, 120 would probably never have
been seen by the treating physician and the patient might not receive the appropriate treatment.
This "break" in the patient care process can be easily overlooked when evaluating a TB program.
If the laboratory network reports the number of MDR DSTs and the TB program reports the total
number of patients on treatment, without an electronic system, it would be difficult to see how
many patients had "fallen through the cracks" between these two institutions.
The differing organization structures of the two health districts allowed for an analysis of how
information systems like e-Chasqui would impact a region where HCs communicated in an
"indirect" fashion. Many countries have a system with "indirect" HCs and it is important to note
that though e-Chasqui had a positive impact on the district as a whole, there was little to no
effect on these establishments. The results here would suggest that the greatest benefit can be
achieved by providing these indirect HCs with internet so that they can reap the advantages of
the information system, even if organizational structure remains the same.
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The randomized trial strongly supports the positive impact of e-Chasqui on reporting efficiency.
However, we feel that the randomized trial only reflects a portion of the impact of the system.
Since e-Chasqui affected the entire laboratory through several quality control and reporting tools,
we performed the before-and-after trial to evaluate the system's effect on the district as a whole.
These data suggest that, indeed, additional benefits may have been gained. For instance, the
proportion of DSTs with laboratory TAT greater than 60 days decreased by more than 50% and
there was a small, but significant decrease in treatment TAT. However, this system was
implemented within a larger project to improve laboratory capacity and as such many other
strategies were implemented during this study period; therefore we cannot attribute the historical
trends solely to e-Chasqui.
There was no significant difference in treatment TAT between the intervention and control HCs.
There are several possible explanations for this, including several factors which weakened the
impact of e-Chasqui. These factors included a) that patients and their samples were assigned to
their initial HC even if they transferred to another HC and b) since e-Chasqui was implemented
programmatically, access to both control and intervention HCs was given to the district director
and all clinicians in the MDR-TB treatment approval committee. Other possible explanations
include that clinicians in the higher burden intervention HCs took longer to have their patients'
MDR-TB regimens approved by the MDR-TB committee or that patients are getting started on
effective standardized regimens and do not need to be modified based on a DST result.
Few prospective, randomized trials have shown that an information system can have a clinical
impact. Here, we find that the patients in the intervention HCs had undetectable levels of TB
after their DST 18 days earlier than those in the control HCs, a 21% decrease in culture
conversion TAT. The mechanism of this impact, however, is unclear since it is not due to an
earlier start of appropriate treatment. We believe that the culture conversion TAT measures not
only the effect of the drug regimen, but other factors that we did not measure directly. Some of
the ways e-Chasqui could contribute to the clinical impact are: 1) improved monitoring of
patients because clinicians have greater access to their bacteriological history; 2) increased
ability to prioritize regimen changes for the patients who would benefit most; 3) improved
adherence by patients because they believe they are receiving better treatment when their doctor
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uses a computer (as seen by the positive patient opinion expressed in the survey); 4) a greater
sense of responsibility because their doctor can monitor them more closely.
The positive user opinions also showed that e-Chasqui had benefits for the HCs users. For
example, despite the fact that half did not have computers at their office, 72% of all users
accessed e-Chasqui at least once a week. Also, 90% of users preferred e-Chasqui or found it as
useful as the paper system. We found that the control HC staff had a favorable opinion of the
benefit of using electronic systems nation-wide and that e-Chasqui users maintained that opinion.
Another possible measure of the success of this system is its continued use and expansion.
During the study period, over 120 users from 79 HCs not in the study cohort were trained in the
use of the system at the request of district administrators. Since the end of the study period,
another 118 users from 68 control HCs have been trained and are using e-Chasqui. In total, e-
Chasqui serves a network of 159 institutions serving a catchment area of over 4.2 million people
and providing treatment to approximately 9,600 TB and 800 MDR-TB patients every year. We
are currently working with the Ministry of Health to transfer the system to their control.
Limitations
There were fundamental baseline differences between the intervention and control HCs despite
the randomized nature of this trial. These differences could introduce bias into the analysis, but
in all cases we used pre-implementation values in our models to account for this. The study was
conducted in the two most populous health districts in Peru. Therefore the generalizability of
these results should be treated with caution. Being in an urban area provided the project with
mostly consistent power and internet, as well as geographic proximity to provide technical
support, which is not the case in many resource-poor settings. Therefore groups implementing
these systems should ensure that the appropriate infra-structure is in place. Also, the data used in
this study is on 1600 of the 1800 patients enrolled in the study. Finally, this was a formative,
rather than summative, evaluation since the developers were involved.
7.5 Conclusion
A carefully designed and implemented web-based tuberculosis laboratory information system
reduced the time to communicate results between laboratories and health establishments spread
throughout a large, peri-urban area. It also prevented many results from taking over two months
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to reach their destination or never arriving. This system was also endorsed by users despite
limited support available and difficulties in accessing the internet. Patients in intervention HCs
had the same time to treatment as those in the control HCs, but they had their first negative
culture after a DST 18 days before those in the control HCs (21% earlier). Such a system in other
resource-poor settings should be considered as a component of laboratory infrastructure to
support TB and MDR-TB care.
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8 Impact of e-Chasqui on Data Quality
In previous chapters, we have described the e-Chasqui laboratory information system and its
impact in reducing delays in communication of results from laboratories to health centers,
changing medication regimens, and having patients culture convert. In this chapter, we analyze
its impact on reducing the number of errors in the laboratory results communicated between the
laboratories and health centers-in other words, its impact on data quality. The description of the
setting and study is similar to the previous chapter. We conducted a cluster randomized
controlled trial to evaluate the effectiveness of the e-Chasqui laboratory information system in
reducing the number of errors in laboratory results used by clinical personnel in the TB program
in Peru. We also performed a before-and-after trial to evaluate additional effects of the system.
8.1 Methods
A cluster randomized controlled trial (RCT) tested the effect of the laboratory information
system e-Chasqui in reducing errors in communicating test results from district laboratories to
health centers. As a secondary study design, we also conducted a before-and-after trial. Both
trials were performed within a larger observational study evaluating the impact of expanded
laboratory capacity in the district laboratories.15
8.1.1 Study Settings and Design
This study was carried out in the same two health districts and format as described in the
previous chapter. The intervention, e-Chasqui, was described in Chapter 6.
We prospectively collected baseline data for 12 months from the two health districts. We then
implemented e-Chasqui in the laboratories and randomly assigned six HCs from each health
district (12 total) to the intervention. In Lima Ciudad, these six were randomized from the 20
highest incidence HCs. In Lima Este, they were randomized from the 12 direct HCs within Lima
city limits (Figure 7.2). Indirect HCs (n=44) belonged to the study arm that was assigned to their
corresponding direct HC. After the intervention was implemented, we collected data on the same
endpoints in control and intervention arms. This allowed us to perform a prospective comparison
between the intervention and the control arms (cluster randomized controlled trial) as well as a
historical comparison comparing the full district pre- and post-implementation (before-and-after
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trial). This complementary design using two comparison groups allowed us to minimize the risk
that the changes measured were due to secular changes in the regions studied or to baseline
differences between the arms. Since the potential sources of bias should be independent,
observing similar effects in both comparisons should offer reassurance that our conclusions are
valid. The Lima Este district laboratory did not perform DSTs before the implementation of e-
Chasqui, hence no baseline DST data for that district is available.
8.1.2 Outcomes
An error was defined as an occurrence when information from the laboratory register did not
match the result found in the clinical chart at the HC. We recorded all relevant variables
collected for DSTs and cultures, including patient name, result date, identification number,
result, and if the result or clinical chart were found at the HC. For the purposes of this thesis, we
only report what we defined as major errors: (1) a change in the patient's name that could result
in mis-identification of the result, (2) difference in result type (negative to positive) or strength
(paucibacillary, +, ++, or +++), (3) paper result not found in the patient's chart, (4) chart not
found at the HC. For the comparison of the patient's name we considered the chart at the HC to
be the gold standard, and the laboratory register was the gold standard (for the result).
We performed a primary analysis comparing the results found on paper in the laboratory register
and the chart at the HC. For purposes of this analysis, if a result or chart was not found at the
HC we did not take into account if it had been viewed in e-Chasqui. We performed two
secondary analyses. First, we analyzed the same data, but counted a result as not missing if it had
been viewed in e-Chasqui by the intervention HC staff. Second, we eliminated all missing result
or chart errors and only considered those results that had reached the HC. We analyzed this
cohort for the number of errors resulting from a wrong name or result.
We expected a decrease in all types of errors. For the randomized controlled trial, we expected
the intervention HCs to have fewer errors because they would have access to all results in e-
Chasqui and therefore should have no missing results. In the before-and-after trial, all data had
to be verified by the laboratory director before being displayed in the web-based system,
therefore we expected that e-Chasqui implementation at the laboratory should decrease errors for
the full district.
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8.1.3 Sample Size
In an earlier study of a collection method for cultures in Peru we had measured the error rate to
be 4%.26 Assuming that the effect estimate of e-Chasqui was to reduce this error rate to 2%,
based on 0.9 power, and an a of 0.05, 262 samples subjects in each group (1048 total) were
required; we collected 2962 cultures and 1743 DSTs.
8.1.4 Data Abstraction
For cultures, we sampled results every four months the year before and after the intervention was
implemented. In Lima Ciudad, the pre-implementation collection dates were the first two weeks
of March, July, and November 2005. The same dates in 2006 were collected for the post-
implementation comparison. In Lima Este, pre-implementation collection dates were the first 23
days of May 2005, September 2005 and January 2006. A higher number of days were sampled
because the Lima Este laboratory performs fewer tests than Lima Ciudad. The same dates the
following year were sampled for post-implementation. For DSTs, we sampled all DSTs
performed pre-implementation and post-implementation in Lima Ciudad (Jan. 17- Dec. 2005 and
Feb. 1-Dec. 31, 2006). No pre-implementation DSTs were performed by Lima Este; we collected
post-intervention DSTs in Lima Este (Dec. 1, 2006-Nov. 15, 2007) to meet our sample size
requirement.
8.1.5 Statistical Analysis
We examined the effect of the intervention at a sample level, adjusting for the impact on
variance of the clustering in the study design. We used a generalized linear mixed model
(GLMM)18 4 185 with HC as a random effect and pre-intervention mean error rate per HC (as a
proxy for HC variance), DST method and number of changes of the TB clinician and nurse per
HC as fixed effects. The pre-intervention error rate should adjust for possible HC differences that
may have been unequally distributed despite randomization. We stratified the analysis by health
district (Lima Este and Lima Ciudad).
8.2 Results
Characteristics of the intervention and control HCs are summarized in Table 8.1. There was no
significant difference in the total number of cultures and DSTs between the intervention and
controls HCs. The only significant difference was the higher number of clinician changes in the
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intervention HCs. 98% of all culture results
were viewed by the intervention HCs.
Table 8.1. Characteristics measures for all study
otherwise.
and 100% of all DST results available in e-Chasqui
health centers (HCs). Values are mean (SD) unless stated
Characteristic Control Intervention p-value
HCs HCs
Total # direct HC 22 12
Total # indirect HCs 27 17
Monthly cultures per HC 12.3 (11.1) 26.3 (28.6) 0.06
Monthly DSTs per HC 2.0 (2.0) 3.4 (3.8) 0.06
Changes in TB clinician per HC during study 1.7 (1.1)* 2.1 (1.1) 0.04
Changes in TB nurse per HC during study 1.4 (0.9) 1.6 (0.9) 0.34
Sample Sizes
Cultures Sampled 539 780
DSTs Sampled 584 765
Before After
Cultures Sampled 1643 1319
DSTs Sampled 394 1349
8.2.1 Primary Analysis
When looking at the paper results, the major source of errors are missing results or charts, which
account for 88-92% of all errors depending on the comparison (Tables 8.2 and 8.3). When
comparing the control and intervention HCs, there was no significant difference in the error rate
for either cultures (p=0.07) or DSTs (p=0.26). For cultures, the Lima Ciudad intervention HCs
had significantly fewer errors than control HCs (p=0.02), though there was no difference in Lima
Este (p=0.35) as seen in Table 8.4. For DSTs, there are no significant differences between
control and intervention HCs (Table 8.6).
In the before-and-after trial for effects of e-Chasqui implementation at the laboratory level, DSTs
in Lima Ciudad had significantly fewer errors after the implementation (p=0.02, Table 8.7). No
significant change was seen in cultures (Table 8.5)
Table 8.2 Number of errors by type in cluster randomized controlled trial
Control Intervention
Number % Number %
Culture Patient Name 7 1.2 14 1.8
Culture Result 4 0.7 1 0.1
Culture Colonies 0 0.0 0 0.0
Culture not found in chart 66 12.2 70 9.0
Chart not found (Culture) 41 7.6 83 10.6
Total 118 21.9 168 21.5
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DST Patient Name
DST Result
DST not found in chart
Chart not found (DST)
10 1.7
1 0.2
57 9.8
23 3.9
Total 91 15.6 140 18.8
Table 8.3 Number of errors by type in before-and-after trial
Before After
Number % Number %
Culture Patient Name 51 3.1 21 1.6
Culture Result 4 0.2 5 0.4
Culture Colonies 0 0.0 0 0.0
Culture not found in chart 139 8.5 136 10.3
Chart not found (Culture) 195 11.9 124 9.4
Total 389 23.7 286 21.7
DST Patient Name 15 3.8 21 1.6
DST Result 1 0.3 5 0.4
DST not found in chart 55 14.0 128 9.5
Chart not found (DST) 60 15.2 79 5.9
Total 131 33.2 233 17.3
8.2.2 Secondary Analysis
We used the event log of e-Chasqui to count all of the results that had been viewed online by at
least one staff member in the intervention HCs. If the result was viewed online then it was not
counted as missing. All DST results and 98% of culture results were viewed online.
The intervention HCs had significantly fewer errors than control HCs for both cultures and DSTs
(Tables 8.4 and 8.6, see Error Rate with e-Chasqui). This decrease remained significant in both
health districts. In the before-and-after trial, there was a significant decrease in errors in all
comparisons after the implementation of e-Chasqui. This includes the overall analysis (cultures
p<0.001, DSTs p<0.001), in Lima Ciudad (cultures p<0.001, DSTs p<0.001), and in Lima Este
(cultures p<0.001).
Table 8.4 Primary and secondary analyses stratified by health district for cultures in RCT. Figures are percent of
samples with at least one error unless stated otherwise.
Outcome Control Intervention Hazard Ratio p-value
(95% CI)
Paper Error Rate 21.9 21.5 0.74 (0.53-1.02) 0.07
Lima Ciudad 27.6 15.2 0.4 (0.18-0.89) 0.02
Lima Este 14.6 27.1 1.49 (0.61-3.64) 0.35
Error Rate with e-Chasqui 21.9 1.9 0.07 (0.02-0.24) <0.001
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Lima Ciudad 27.6 0.5 0.003 (0.002-0.10) <0.001
Lima Este 14.2 3.2 0.22 (0.06-0.79) 0.02
Wrong Name or Result 1.9 1.9 1.28 (0.42-3.93) 0.65
Lima Ciudad 0.7 0.5 Model did not converge
Lima Este 3.2 3.2 1.32 (0.39-4.46) 0.63
Table 8.5 Primary and secondary analysis stratified by health district for cultures in the before-and-after trial.
Figures are percent of samples with at least one error unless stated otherwise.
Outcome Before After Hazard Ratio p-value
(95% CI)
Paper Error Rate 23.8 21.5 0.89 (0.73-1.07) 0.21
Lima Ciudad 23.3 20.7 0.83 (0.64-1.08) 0.16
Lima Este 24.2 22.4 0.94 (0.72-1.22) 0.63
Error Rate with e-Chasqui 23.8 9.9 0.36 (0.28-0.47) <0.001
Lima Ciudad 23.3 12.5 0.48 (0.36-0.65) <0.001
Lima Este 24.2 7.3 0.25 (0.17-0.36) <0.001
Wrong Name or Result 3.3 1.9 0.56 (0.34-0.92) 0.02
Lima Ciudad 2.6 0.6 0.20 (0.07-0.55) 0.002
Lima Este 3.9 3.2 0.77 (0.43-1.39) 0.39
In the second analysis, we compared the error rates among results at the HCs (Wrong Name or
Result in Tables 8.4-8.7) by excluding the missing results and chart errors. No difference was
seen between control and intervention HCs in the overall or health district comparison for
cultures (Table 8.4) or DSTs (Table 8.6). In the before-and-after trial, cultures had a significant
decrease post-implementation in the overall analysis (p=0.02) and in Lima Ciudad (p=0.002,
Table 8.5). No significant difference was seen in Lima Este. For DSTs, there was a decrease in
the overall analysis (p=0.05) and in Lima Ciudad (p=0.02) post-implementation (Table 8.7).
Table 8.6 Primary and secondary analysis stratified by health district for DSTs in the RCT.
samples with at least one error unless stated otherwise.
Outcome Control Intervention Hazard Ratio p-value
(95% CI)
Paper Error Rate 15.6 18.8 1.21 (0.87-1.70) 0.26
Lima Ciudad 18.2 16.3 1.2 (0.36-3.93) 0.75
Lima Este 13.0 21.9 1.6 (0.75-3.38) 0.21
Error Rate with e-Chasqui 15.6 1.4 0.11 (0.06-0.22) <0.001
Lima Ciudad 18.2 1.2 0.12 (0.02-0.97) 0.047
Lima Este 13.0 1.2 0.08 (0.03-0.24) <0.001
Wrong Name or Result 1.9 1.9 1.23 (0.49-3.05) 0.66
Lima Ciudad 0.7 2.4 4.67 (0.16-139.8 0.19
Lima Este 2.9 1.5 0.42 (0.13-1.38) 0.15
Table 8.7 Primary and secondary analysis stratified by health district for DSTs
are percent of samples with at least one error unless stated otherwise.
Figures are percent of
in the before-and-after trial. Figures
Outcome Before After Hazard Ratio p-value
(95% CI)
Paper Error Rate 33.2 17.3 0.41 (0.30-0.57) <0.001
Lima Ciudad 33.2 17.0 0.45 (0.32-0.65) <0.001
Lima Este 17.7
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Error Rate with e-Chasqui 33.2 7.8 0.18 (0.12-0.27) <0.001
Lima Ciudad 33.2 8.6 0.19 (0.12-0.29) <0.001
Lima Este 7.0
Wrong Name or Result 4.1 1.9 0.50 (0.26-0.99) 0.05
Lima Ciudad 4.1 1.7 0.41 (0.19-0.89) 0.02
Lima Este 2.1
Errors in the after group include both control and intervention HCs post-implementation and
therefore the error rates average the errors of both the electronic and the paper system..
The RCT in the previous table measures the impact of HC access to e-Chasqui, whereas the
before-and-after trial in this table measures the impact of e-Chasqui on the laboratory and hence
all of the HCs in the district.
8.2.3 Usability and Acceptability of System
The response rate among intervention HC users administered the survey was 94% (29 of 31),
though 23 users were not administered the survey because they were not present at their HC
during the visit. The response rate among control HC users was 93% (108 of 116). Of the
intervention HC users, 48% (n=14) were clinicians or nurses in charge of the patients treatment
(Table 8.8). The intervention HC users had, on average, more years of internet usage and had
accessed the internet more frequently from the TB office or laboratory. Both of these can be
attributed to e-Chasqui since the survey was given after three years of using the system and the
district office had prioritized internet access for those TB offices in intervention HCs.
Table 8.8 Survey respondent characteristics with number (percentage) of users
Controls Intervention
Characteristic (n=108) (n=29)
Gender
Male 27 (25) 12 (41)
Clinical background
Physician 20 (19) 6 (21)
Nurse 35 (33) 8 (28)
Laboratory staff 9 (8) 3 (10)
Nurse technician 36 (34) 10 (34)
Other 5 (5) 2 (7)
Years of Internet usage
0 26 (25) 2 (7)
1-5 47 (44) 18 (62)
6-10 25 (24) 6 (21)
>10 1 (1) 1(3)
Location of Internet usage
TB office/laboratory 16 (15) 15 (52)
Office in health center 17 (16) 4 (14)
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House 56 (53) 12 (41)
Internet cabin 36 (34) 7 (24)
Other office 17 (16) 3 (10)
Other 3 (3) 0
Health district
Lima Ciudad 88 (83) 17 (59)
Lima Este 17 (16) 12 (41)
A majority of users were missing at least 10% of results in the paper system (66% for control
HCs, 55% for intervention HCs) and approximately the same proportion felt that this diminished
the opportunity of treatment given to a patient. All of these users in the intervention HCs found
results in e-Chasqui they did not have on paper.
Control HC users thought that an electronic system would be more complete, confidential, and
secure than the current paper system. This same pattern is seen in the responses of the
intervention HC users when asked about e-Chasqui.
Table 8.9 User opinion of paper and e-Chasqui systems. Responses are mean of five-point Likert scale anchored by
1=very negative, 5=very positive or number (percentage) of option chosen. Percentages are calculated from total
surveys even if question was left blank.
Frequency (%)
Controls Intervention
(n= 108) (n=29)
How often were you missing a culture or DST result for a patient? (paper
system)
1 of 2 patients 27 (25) 2 (7)
1 of 4 21 (20) 3 (10)
1 of 10 22 (21) 11 (38)
1 of 50 13 (12) 2 (7)
1 of 100 2 (2) 0
Never 17 (16) 7 (24)
Do you believe this diminished the opportunity of treatment?
Yes 80 (75) 16 (55)
No 20 (19) 6 (21)
Did you find information in e-Chasqui that you would not have had without
the system?
Yes 20 (69)
No 9 (31)
In which system do you believe the information is more complete (the
requests are filled out better)?
Electronic / e-Chasqui 83 (78) 21 (72)
Paper 0 (0) 1 (3)
Both are the same 18 (17) 6 (21)
In which system is the information more confidential (accessible only to the
appropriate personnel)?
Electronic / e-Chasqui 77 (73) 27 (93)
Paper 4 (4) 0
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Both are the same 21 (20) 1 (3)
In which system is the data more secure (will not lost)?
Electronic / e-Chasqui 84 (79) 26 (90)
Paper 4 (4) 0
Both are the same 12 (11) 2 (7)
8.3 Discussion
This study showed that there was no significant difference in the number of errors in the paper
results found at HCs with or without e-Chasqui. Missing results or patient charts account for
approximately 90% of these paper errors. When taking into account the online viewing of results
by the intervention HC personnel, there is a substantial decrease in errors. Intervention HCs had
a 91% reduction in errors for both cultures and DSTs as compared with control HCs. This
confirms that e-Chasqui access at the HC level had a significant impact in reducing the error rate,
mostly by providing access to results otherwise unavailable in the paper system.
When the missing results or patient chart errors were eliminated, the error rate found at all HCs
post-implementation was lower for both cultures and DSTs-that is to say, if the result was
found at the HC, it was more likely to be correct after e-Chasqui implementation. This confirms
that e-Chasqui access at the laboratory level (which affects the entire district) had a significant
impact in reducing the misspelling of names and reporting of wrong results.
In surveys, a majority of control and intervention HC users reported that they were missing at
least 1 in 10 results. This validates our study's results where we found that 15.4 to 29.2% of all
culture and DST results were not found at the HC. More importantly, almost 70% of e-Chasqui
users reported finding results electronically that had been missing in paper form. This may be
the system's largest impact.
We have not found reviews of the number of errors or missing results in other resource-poor
settings, but our experience working in developing countries makes us believe that they are of
the same or greater magnitude than what we have found here.' 65 211 212 A high rate of missing
results can occur easily within a paper system. This is aggravated by many factors found in the
public health care system in most developing countries. Among some of the likely causes are a
high patient load, lack of staff to support the administrative requirement of a paper system,
inconsistent transportation of samples and results between HCs and laboratories, and the lack of
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storage space or organization for charts. The results of this study show that the electronic system
did not improve the proportion of paper results found at the HC. The fact that all DSTs and 98%
of cultures in the system were viewed online by point-of-care healthcare providers demonstrates
that electronic medical record reporting systems like e-Chasqui can improve not only the timely
delivery of results, but also the quality of results, which facilitates, in turn, quality of care.
Limitations of study
The data were collected at approximately the same time for both pre and post implementation
phases. Because of this, the pre-implementation data needed to be stored longer at HCs and
therefore was more likely to be missing. Though this is a disadvantage of any paper system, it
does imply a bias in the before-and-after trial. The study was conducted in the higher burden
HCs in the two most populous health districts in Peru, therefore the generalizability of these
results should be treated with caution. We think that a higher rate of missing results can be
expected for a paper system in more rural or sparsely populated settings, though this should not
be the case for an electronic system. A more rural setting however can imply less consistent
power or internet availability, making it harder to access an electronic system. Finally, this was a
formative, rather than summative, evaluation since the developers of e-Chasqui were involved.
8.4 Conclusion
An electronic system substantially reduced the number of missing laboratory results at point-of-
care healthcare sites via electronic viewing, while the rate of missing results or errors on paper
remained unchanged. Clinical users reported that the system provided them with results that were
not received via the paper system. Further studies are required to investigate the impact of this
online availability on patient outcomes.
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9 Conclusions and Future Work
9.1 Conclusions
This work had two major goals.
1. To develop informatics tools and an implementation methodology for those tools to improve
the communication of tuberculosis laboratory results in resource-poor settings with and
without internet.
2. To evaluate those tools, using randomized controlled trials with a before-and-after
comparison, to show their impact on decreasing communication delays, improving data
quality, and reducing the time for patients to show clinical improvement.
9.1.1 Developing Informatics Tools and Implementation Methodologies
The two systems developed as part of this work show that laboratory information systems can be
implemented in a resource-poor, peri-urban area. Both systems used a common implementation
methodology which we believe account for a large part of their successful implementation. The
major themes are:
1. Implement healthcare technologies within larger collaborations that improve the overall
public health infrastructure even if this means additional work and time.
2. Create a system technically flexible enough to meet the stakeholder's needs that will be
discovered throughout the implementation process.
3. Involve all personnel who will be using or be impacted by the system. In a public health
context this especially includes the end users such as clinicians, nurses, and data entry
personnel, who can be easily left out of the process.
4. Have local political support for the project from its conception. Unless there is will from the
administration to implement an electronic information system, promote its use, and allocate
resources to maintain it, there is little chance of success.
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5. Focus on the needs of the users. Trainings should be focused on the benefits the system
provides the users. In Peru, most previous health information systems required users to enter
data for reporting purposes without receiving any feedback. In this work, we saw reticent
users become enthusiastic when they realized the system would provide them with useful
information.
6. Share the lessons learned of the process. This could be done by making available the plans,
times, and costs of implementing any system available through academic publications or
internet sites focused on resource-poor settings such as the Global Health Delivery online
communities.213
9.1.2 Evaluation of the Impact of the Informatics Tools
Any medical informatics tool implemented should be evaluated to ensure its safety and the
impact it has on patient care. This work showed that well-designed and implemented electronic
systems can provide for major improvements in a peri-urban, resource-poor setting. Among the
improvements were:
1. Reducing the median time to communicate a result, in the case of the handheld system from
23 to 8 days.
2. Reducing the proportion of tests with large communication delays, in the case of the
handheld system, from 9.2% to 0.1%.
3. Ensuring that results reach the clinician. Approximately 20% of results could not be found
on paper at the e-Chasqui health centers, yet all were viewed in the system by the staff.
4. Reducing the work load on already overburdened clinical and administrative personnel. The
handheld system reduced the number of work-hours necessary to process results by 60%. E-
Chasqui virtually eliminated clinicians phone calls to the laboratory to enquire about the
status of their sample by providing them with the ability to track their samples online.
128
9.2 Recommendations for Future Work
The need to improve communications and treatment in settings of poverty is both dire and
daunting. This thesis presented data on how laboratory information systems can be implemented
in resource-poor settings with and without internet and shows their impact on clinical and
administrative criteria. However, much more work needs to be done in developing robust
medical information systems for these harsh settings, creating methodologies to ensure their
successful implementation, and performing quantitative evaluations to determine their impact on
clinical care.
For developing robust systems, factors such as intermittent internet and power, little to no
computer experience, and high staff rotation, need to be taken into account and provide
additional challenges to the already difficult task of successfully implementing medical
informatics applications. One factor that will help in this process is the philosophy of open
source software and community. There are already three major open source projects developing
systems and communities that are empowering projects in resource-poor settings. The goals are
to provide better clinical care, but also to empower them to become more self-sustainable by
promoting the creation of local businesses and developers and giving them tools on which they
can build without being dependent on companies in the developed world. One such movement is
centered around OpenMRS, 196 197 a general purpose medical record system architecture we have
developed with colleagues in the US and Africa to support TB and HIV treatment programs. We
have also seen this occur with our local Peruvian organization, Socios En Salud, which has
developed the technological capacity to manage the systems developed during this thesis and to
be able to implement them in other areas or countries in need.
Implementation methodologies are also needed so that resource-poor settings do not make the
same mistakes as many developed countries. These methodologies should focus on both the
local and national level. For local institutions they should describe the holistic approach of
implementing information systems. This holistic approach includes understanding the
information flows throughout their organization, standardizing forms and terminology, and
creating workspaces amenable to the use of information technology. A myriad of proven
methodologies will be required for the different types of institutions and contexts all over the
world where medical informatics applications can be of use.
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These methodologies should prevent organizations from making the same mistakes that many
clinical organizations who have implemented information systems. Among the most common
mistakes are: 1) simplifying the challenge of implementing medical information systems to
installing computers and software, 2) not controlling the ownership of the systems they
implement thereby becoming dependent on a company for any change, 3) using systems that do
not inter-operate, not allowing for communication with other systems in their own institution and
in other institutions. At a national level, countries should learn the importance of having a vision
and plan to create inter-operable systems and having these systems reduce the workload on an
already overloaded workforce by, for example, having clinical systems report consolidated data
to district-wide information systems, rather than having the clinical staff manually create these
reports. Also, these methodologies should outline the optimal order of implementation of
systems depending on the situation and needs of a country, the requirements, costs, and times of
such implementations, and factors external to the systems that need to be in place for success.
Finally, further evaluations and improved evaluation methodologies will be required to ensure
that patients and countries are actually benefiting from the investment in medical informatics
applications. At the time of this work, these were the only randomized controlled trials
performed on laboratory information systems in resource-poor settings and they were among
only a handful of randomized trials performed on any medical information system. More such
trials are needed to determine if medical informatics can deliver its promised benefits.
Large investments are currently being made in medical informatics for resource poor settings.
We believe that this work has provided a critical foundation for how this investment should be
used and how information systems should be developed and implemented. First, they must be
carefully designed with the end users in mind and taking all stakeholders into account, especially
those on the ground. Many systems implemented are only for reporting purposes and, though
perhaps useful for national statistics, are a burden on usually over-worked clinical and
administrative staff. A better option is to implement a clinical system from which a reporting
system could automatically consolidate required data. This benefits both the on the ground staff
and the national offices. Second, there must be local interest and political support to implement
the system. Systems should not be imposed by an external party. This is a difficult position
since most funding sources have deadlines or policies that prevent long-term relationships where
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such collaboration can happen. Finally, when possible, the information system should be
implemented as part of larger structural improvement within the public health sector. The
implementation of an information system will require a change in workflows. By being part of a
larger project, this change in workflow will be easier to implement since other factors are
changing as well and the system will not just be replicating a potentially poorly designed
workflow. Also, there are many difficulties in working in resource-poor settings. When a more
holistic approach is taken to the implementation, more possible failure points will be addressed.
If only the information system was implemented other external factors could lead to its failure.
It is also preferable to work within the public health sector to ensure the sustainability of the
project by training local personnel and strengthening already existing infra-structure.
This work has shown that if a medical information system is implemented according to the
principles described it may have a large impact on the care provided to patients. It has also
shown that these systems can be evaluated in a resource-poor setting. This we hope will be a call
to others that systems being implemented in settings of poverty must be validated and evaluated
to ensure that the optimal care is being provided. Currently, most systems being implemented in
the field have not been evaluated.
Finally, we believe that these are foundational studies for the emerging field of global health
informatics. These initial randomized controlled trials show that these laboratory information
systems are a worthwhile investement both in terms of the benefits they provide and the costs to
implement. We hope that this work will inspire others to invest in this work in a communal and
scientific way, as described here.
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Appendix A Palm Project User Survey
Encuesta de Usuarios del Proyecto Palm
Por favor, tome algunos minutos para completar la siguiente encuesta sobre su
satisfaccion con respecto al motodo de recolecciOn de datos del Proyecto Palm.
Preguntas sobre el uso del sistema de papel
1. En promedio, &Cuantos aflos ha trabajado con el sistema de papel para recolectar
datos bacteriol6gicos?
2. En general, iQus tan satisfecho/a se encuentra usted usando el sistema de papel como
m6todo de recolecci6n de datos? (marque s6lo una respuesta):
L Muysatisfecho U Algo satisf6cho L Nisatisfecho ni LI Algo Insatisfecho Li Muy insatisfecho
insatisfecho
3. En promedio, por cada dato LCuantos minutos le toma
bacteriol6gico hasta ingresarlo al EMR?
O 0 - 2 minutos
EI 2 - 4 minutos
D 6 - 8 minutos
O 8 minutos o mas
en total desde recolectar un dato
A. Su aprendizaje en como usar el sistema de papel
para recolectar datos bacteriol6gicos
D. El entrenamiento recibido acerca de como usar el
sistema papel para recolectar datos bacteriol6gicos L I
C I
o I
5. ZCual considera usted la mayor ventaja de usar el sistema de papel?
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6. 6Cucl considera usted la mayor desventaja de usar el sistema de papel?
I
Preguntas sobre el uso del sistema Palm
Estas preguntas son sobre el sistema Palm DESPUES de que comenz6 el estudio el 20 deMarzo, 2006. Por favor, responda estas preguntas teniendo solo ese periodo en mente.
1. En promedio, ,Cuantos anos de experiencia tiene usando el Internet?
2. En promedio, LCuantos afos ha trabajado con el PIH-EMR?
3. En general, ZCucn satisfechola se encuentra usted usando el sistema Palm como metodode recoleccion de datos? (marque s6lo una respuesta):
U Muy satisfecho L Algo satisfecho Ni satisfecho ni UAgo insatisfecho [ Muy insatisfecho
insatisfecho
4. En promedio, por cada dato &Cuintos minutos le toma
bacteriologico hasta ingresarlo al EMR?
O 0 - 2 minutos
O 2 - 4 minutos
Li 6 - 8 minutos
LO 8 minutos o mis
en total desde recolectar un dato
A. Su aprendizaje en como usar el sistema Palm para
recolectar datos bacteriol6gicos 1 I 0 1
D. El entrenamiento recibido acerca de como usar el
sistema Palm para recolectar datos bacteriologicos O I O I
A. Beneficio de tener la lista de pacientes activos
en la palm
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C. Uso del puntero y los botones de la palm para
el ingreso de datos
D. Ayuda de pdgina de Tabla de Errores para
procesar datos bacteriologicos
5. LCuIl considera usted la mayor ventaja de usar el sistema Palm?
6. &Cucl considera usted la mayor desventaja de usar el sistema Palm?
7. AC6mo cree que el uso de la Palm fue percibido por el personal de salud con quien usted
interactua?
2 Muy Positivo j0 Positivo 0 Normal 0 Negativo 1 0 Muy Negativo
8. AC6mo cambio su relaci6n con el personal de salud por el uso de la Palm?
9. En promedio, &Cudntas veces al mes tuvo problemas con la Palm?
U 0 veces
U 1-2 veces
O 3-4 veces
I 5-6 veces
U 7 veces o mas
10. En promedio, LDe que severidad eran estos problemas que tuvo con la Palm?
U Lo podia arreglar en ese instante y continuar mi trabajo
U Tenia que continuar en papel ese dia y lo podia arreglar en la oficina solo/a o con el
equipo de BK
U Tenia que continuar en papel ese dia y lo podia arreglar en la oficina con ayuda t~cnica
U No lo podia arreglar
11. LTiene alguna sugerencia de c6mo mejorar el sistema Palm?
147
12. &Cual de los dos metodos prefiere usted prefiere? (Elija solo una alternativa):
LI Prefiero recolectar datos con el sistema Palm
I) Prefiero recolectar datos con el sistema de papel
O No tengo preferencia por uno u otro metodo.
Comentarios adicionales: Por favor utilice este espacio y la siguiente hoja de ser necesaria
para comentarios adicionales que usted desee hacer con respecto al metodo ylo al proceso de
coleccion de datos o sobre la presente encuesta. Su opinion es muy valiosa.
(Por favor use la siguiente hoja de ser necesario)
GRACIAS POR COMPLETAR LA PRESENTE ENCUESTA!!!
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Appendix B e-Chasqui and Control User Survey
B.1 e-Chasqui User Survey
E-CHASQ UI[4$is% Owtc eMb t(A 1- -"W
Por favor, tome algunos minutos
el sistema e-Chasqui.
Encuesta de Usuarios
para completar la siguiente encuesta sobre su satisfacci6n con
Informacidn Demografica
4. Sexo:
L1 Femenino
5. Indique su cargo:
L Administrador
O Enfermera
0 Laboratorista
O Masculino
LI Doctor
LI Tecnica/Auxiliar de Enfermeria
L1 Otro (por favor especificar):
6. LEn cual DISA trabaja?
7. En promedio, LCudntos anos tiene usando el Internet? (Si no usa el Internet, ponga 0)
8. &Donde usa el Internet usted actualmente? (Elija todas las alternativas que sean
correctas)
L Programa de PCT/Laboratorio
Li Mi casa
L Oficina
O Otra oficina de un Establecimiento de Salud
Li Cabina de Internet
L Otro (por favor especificar):
Preguntas sobre el sistema e-Chasqui
9. En promedio, &Cudntas veces ingresa usted al e-Chasqui?
O Varias veces al dia
" Una vez a la semana
03 Una vez al dia
l Una vez al mes
l Casi nunca
10. En general, .Cuan satisfecho/a se encuentra usted usando el sistema e-Chasqui para
comunicar los resultados de pruebas de TBC? (marque s6lo una respuesta):
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i Muy satisfecho I Algo satisfecho Ni satisfecho ni LAlgo insatisfecho L1 Muy insatisfecho
insatisfecho
11. LUsted usa el e-Chasqui durante la visita de un paciente? (Elija solo una alternativa)
IO Mas de la mitad de mis pacientes O Menos que la mitad
1 Menos de un cuarto 0 Muy pocos
O Ninguno
12. Si respondio afirmativo a la previa pregunta, &Qu cantidad de pacientes han expresadoque encuentran el e-Chasqui beneficioso?
O 1 de cada 2 pacientes 0 1 de cada 4 pacientes
O 1 de cada 10 pacientes 01 1 de cada 50 pacientes
0 1 de cada 100 pacientes 0 Ninguno
13. &Pudo encontrar informacion en el e-Chasqui que no hubiera tenido sin el sistema?
O Si O No
14. En que forma influyo esta informaciOn en sus decisiones para el paciente?
O
0
A. Recibir un correo electrbnico diario
con mis resultados recientes
B. Poder ver la lista de pruebas
pendientes
C. Poder ver resultados de mis
pacientes en otros establecimientos
D. Tener acceso al sistema facilmente
y en cualquier lugar
16. cCuMl considera usted la mayor ventaja de usar el e-Chasqui?
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17. &Cual considera usted la mayor desventaja de usar el e-Chasqui?
Preguntas sobre el sistema de papel
18. En el sistema actual de papel, 6 Con que frecuencia usted no encuentra un resultado de
cultivo o prueba de sensibilidad que existe?
I 1 de cada 2 pacientes LI 1 de cada 4 pacientes
L 1 de cada 10 pacientes LI 1 de cada 50 pacientes
I 1 de cada 100 pacientes LI Nunca
19. En referencia a la previa pregunta, LUsted cree que esto disminuye la oportunidad del
tratamiento dado al paciente?
O Si I No
20. Si respondio Si, LC6mo cree que esto disminuye la oportunidad?
151
21. En general, _Que tan satisfecho/a se encuentra usted usando el sistema de papel para
comunicar los resultados de pruebas de TBC? (marque solo una respuesta):
ICMuy satisfecho 1 Algo satisfecho L Ni satisfecho ni AlAgo insatisfecho IO Muy insatisfecho
insatisfecho
Comparacion del e-Chasqui con el sistema de papel
22. En cual sistema cree que la informacion estaria mas completa (las solicitudes estan
Ilenadas mejor)? (Elia solo una alternativa):
C El sistema e-Chasqui
LO El sistema actual de papel
O Los dos sistemas son iguales
23. .En cual sistema cree que la informacion seria mas confidencial (accesible solo al
personal adecuado)? (Elija sblo una alternativa):
LI El sistema e-Chasqui
O El sistema actual de papel
" Los dos sistemas son iguales
24. En cual sistema cree usted que la informacion estaria mas segura (no se perdera)?:
LI El sistema e-Chasqui
L El sistema actual de papel
O Los dos sistemas son iguales
25. ACucl de los dos sistemas prefiere usted para ver sus resultados? (Elija sOlo una
alternativa):
L El sistema e-Chasqui
1 El sistema actual de papel
LI Los dos sistemas son iguales
Expansion del e-Chasqui
26. &Lo ve adecuado expandir el sistema a otras Direcciones de Salud?
LI Si 3 No
27. &Como cree usted que usando el e-Chasqui en otras Direcciones de Salud impactaria la
calidad del tratamiento al paciente?
U Mejoraria J Mejoria J No mejorara 0 Empeorara
mucho un poco ni empeoraria un poco
U Empeorarfa
mucho
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B.2 Control User Survey
Encuesta de personal de TBC
Por favor, tome algunos minutos para completar la siguiente encuesta sobre su satisfaccion con
el motodo actual de comunicar los resultados de pruebas de TBC y la posibilidad de usar un
sistema electronico basado en el Internet.
Informacidn Demografica
1. Sexo:
Q Femenino
2. Indique su cargo:
Q Administrador
I) Enfermera
L3 Laboratorista
3. En cual DISA trabaja?
4. En promedio, LCuantos
Q Masculino
I) Doctor
" Tecnica/Auxiliar de Enfermeria
" Otro (por favor especificar):
ahos tiene usando el Internet? (Si no usa el Internet, ponga 0)
5. ,Donde usa el Internet usted actualmente? (Elija todas las alternativas que sean
correctas)
O Programa de PCT/Laboratorio
L Mi casa
Oficina
O Otra oficina de un Establecimiento de Salud
LO Cabina de Internet
I Otro (por favor especificar):
Comunicacidn de de resultados bacterioldgicos
6. En el sistema actual de papel, LCon que frecuencia a usted le falta un resultado de cultivo o
prueba de sensibilidad que existe para un paciente? (marque solo una respuesta)
LO 1 de cada 2 pacientes
L 1 de cada 10 pacientes
L 1 de cada 100 pacientes
L0 1 de cada 4 pacientes
L 1 de cada 50 pacientes
Q Nunca
7. En referencia a la previa pregunta, Usted cree que esto disminuye la oportunidad del
tratamiento dado al paciente?
LO S L No
8. Si respondid Si, &C6mo cree que esto disminuye la oportunidad?
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9. En general, &Quo tan satisfecho/a se encuentra usted usando el sistema de papel para
comunicar los resultados de pruebas de TBC? (marque solo una respuesta):
L Muy satisfecho L Algo satisfecho L) Ni satisfecho ni [ Algo insatisfecho LU Muy insatisfecho
insatisfecho
10. LEn cual sistema cree que la informacion estaria mds completa?
alternativa):
(Elija solo una
0L Un sistema electronico basado en el Internet
Ci El sistema actual de papel
LO Los dos sistemas son iguales
11. LEn cual sistema cree que la informacion seria mds confidencial (accesible solo al
personal adecuado)? (Elija solo una alternativa):
L1 Un sistema electronico basado en el Internet
" El sistema actual de papel
" Los dos sistemas son iguales
12. LEn cual sistema cree usted que la informacion estaria mas segura (no se perdera)?:
Li Un sistema electronico basado en el Internet
L El sistema actual de papel
Li Los dos sistemas son iguales
Uso de Sistemas Electronicos a Nivel Nacional
13. ACree usted que se puede mejorar la calidad del tratamiento al paciente usando un
sistema basado en el Internet para comunicacion de pruebas de TBC a nivel nacional?
L Si 1 No
14. &Cree usted que es factible/posible implementar tal sistema a nivel nacional?
O Si L No
Comentarios adicionales: Por favor utilice este espacio y la siguiente hoja de ser
necesaria para comentarios adicionales que usted desee hacer con respecto al motodo ylo al
proceso de comunicacion de resultados o sobre la presente encuesta. Su opinion es muy
valiosa.
(Por favor use la siguiente hoja de ser necesario)
iGRACIAS POR COMPLETAR LA PRESENTE ENCUESTA!
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